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ABSTRACT 
NORA E. ROSENBERG: Assessing the Prevention Impact of HIV Counseling and Testing  
in the South African Context 
 (Under the direction of Audrey E. Pettifor) 
 
HIV counseling and testing (HCT) is rapidly being brought to scale in South Africa,  yet 
its impact on sexual behavior and HIV incidence is not well understood. The purpose of Aim 1 
was to assess whether HIV-infected persons in HIV-discordant couples were less likely to engage 
in unprotected sex after HCT. Self-reported behavioral data from 500 HIV-infected South 
Africans enrolled in Partners in Prevention HSV/HIV Transmission Study was used. The sexual 
behavior of two groups was compared: HIV-infected persons who had just learned their HIV 
status from HCT (< 7 days before baseline) and those who previously learned their HIV status 
from HCT (> 30 days before baseline). Among those tested <7 days before baseline the predicted 
probability of unprotected sex was high at baseline (0.71), declined in month one (0.08) and 
remained lower at month twelve (0.08). Among those tested >30 days before baseline the 
predicted probability of unprotected sex was lower at baseline (0.26), declined futher by month 
one (0.14) and remained lower at month twelve (0.19). These findings suggest HCT lead to 
substantial reductions in unprotected sex. In the second aim, the effect of HCT on future HIV 
acquisition among HIV-uninfected youth was assessed. A retrospective cohort study of 3959 
HIV-uninfected youth 15-24 years-old was conducted using a demographic and health 
surveillance from KwaZulu-Natal, South Africa (2006-2011). Young persons who reported 
knowing their HIV status from HCT were compared to those who reported not knowing their 
HIV status from HCT for time to HIV seroconversion using marginal structural Cox proportional 
hazards models. In these models, after weighting for confounding and censoring, HCT was 
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protective [HR: 0.59, 95% CI:  0.44, 0.78], underscoring the importance of HCT for youth. In the 
third aim a framework was developed to describe nine “awareness patterns” within HIV-
discordant dyads considering both HCT and HIV disclosure together. It was hypothesized that 
different types of HCT lead to different awareness patterns and that certain patterns are more 
strongly associated with uptake of and adherence to behavioral and biomedical HIV prevention 
strategies. Better understandings of these associations may inform how to optimize HCT delivery 
for prevention.  
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CHAPTER I: Specific Aims  
 
HIV counseling and testing (HCT), which is rapidly being brought to scale throughout 
sub-Saharan Africa (SSA), has been promoted as an HIV prevention intervention by UNAIDS 
and the World Health Organization [1-3]. However, evidence for the prevention effectiveness of 
HCT in individuals [4] and couples is of limited rigor [5-6]. This deficit makes it difficult to 
determine how aggressively to promote HCT compared to more rigorously evaluated HIV 
prevention interventions, and how aggressively to promote individual- versus couple-HCT.  
Additionally, this question has primarily been studied in adults, and findings may differ in youth 
ages 15-24. 
In SSA, the prevention effectiveness of HCT has been assessed in a number of 
randomized and observational studies with behavioral endpoints. For those who test HIV-
positive, awareness of HIV status has been associated with an increase in protective behaviors [7-
16]. For those who test HIV-negative, awareness seems to have neither an overall increase nor 
decrease in protective behaviors, but considerable variability exists [7, 9, 12, 17-18]. For HIV-
discordant couples who test together, mutual awareness has been associated with extremely high 
levels of behavior change, levels that surpass those of HIV-positive or HIV-negative persons 
testing individually, [7, 17] though selection factors may play a role [19].  
In SSA, persons who test HIV-negative appear slightly more likely to acquire HIV than 
those who have never tested based on one randomized study [4] and two limited observational 
studies [12, 18]. However, all had insufficient sample sizes, and did not account for bias due to 
survey non-participation. Additionally, all were conducted primarily among adults.  
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 In this dissertation, I assessed the relationship between HCT, behavior change, and HIV 
acquisition as HCT was becoming widely available in South Africa. These issues were addressed 
in three manuscripts: 
In Aim 1 I assessed whether awareness of being HIV-positive was associated with 
less unprotected sex in HIV-discordant couples. Using self-reported awareness and sexual 
behavior data collected from three South African sites in the Partners in Prevention HSV/HIV 
Transmission Study from 2004-2008, I compared those who were tested for HIV recently (in the 
week before baseline) to those who were tested for HIV previously (prior to the month before 
baseline) for levels of unprotected sex in the last month at four time points: baseline, month one, 
month six, and month twelve. I hypothesized that at baseline those recently tested would report 
more unprotected sex acts than those previously tested due to lack of awareness for most of the 
previous month. I also hypothesized that once both groups had been aware of their own HIV 
status and their partner’s HIV status for the entire preceding month that sexual behavior would 
be comparable. 
In Aim 2 I assessed whether HIV-negative youth who received HCT were more 
likely to acquire HIV than HIV-negative youth who had not received HCT. In this aim, I 
used HCT and sero-status data from a large, longitudinal household-based survey collected by the 
Africa Centre for Health and Population Studies in South Africa. I hypothesized that HIV 
acquisition rates would be higher in those who were aware of their HIV status from HCT. This 
was the first longitudinal study to assess this question among young persons aged 15-24. 
Additionally, I expected it would be one of the first studies to assess the relationship between 
HCT and HIV acquisition with sufficient statistical power and the ability to address time-varying 
confounding appropriately.  
In Aim 3 I developed an Awareness Framework to characterize nine possible 
combinations of awareness of HIV status within HIV-discordant couples. I also described 
how this Framework relates to HIV prevention. Awareness of one’s own HIV status and one’s 
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partner’s HIV status are often considered separately. In this thought piece I developed a 
framework for considering these two types of awareness together. Existing research was 
discussed within this framework, research gaps were identified, and strategies to address these 
gaps were proposed. This is not a hypothesis-driven aim, but rather a hypothesis-generating aim. 
This dissertation improves upon the existing understanding of awareness of HIV status, 
sexual behavior, and HIV prevention with a particular focus on the South African context. This 
understanding is critical for maximizing the prevention impact of HCT. 
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CHAPTER II: Background 
Significance  
Over the last decade, the response to the HIV epidemic in sub-Saharan Africa (SSA) has 
intensified dramatically. A decade ago, few people had access to HIV treatment and few knew 
their HIV status. Today, millions of HIV-infected people in SSA have access to life-saving highly 
active antiretroviral therapy (HAART) [1] and in order to identify HIV infected persons and link 
them to treatment, millions test for HIV each year [1-4].  
 
HIV counseling and testing in South Africa  
In recent years, South Africa, the country with the world’s largest burden of HIV [3], has 
become increasingly aggressive in its response to the HIV epidemic with HIV counseling and 
testing (HCT) becoming a central pillar of this response. In 2003 HAART became available in the 
public sector for the first time [5] and HCT was needed to support linkage to care. In South 
Africa’s 2007-2011 HIV/AIDS Strategic Plan, HCT was promoted as a “gateway into HIV 
prevention, treatment, and care” and aggressive HCT targets were set [6]. However, in 2009 
South Africa was not on track to reach these targets, and a national campaign was launched to 
mobilize many South Africans to get tested from April 2010 to June 2011 [6]. On the supply side, 
test kits were made available in clinics throughout the country and HCT was encouraged for all 
persons attending a health facility. On the demand side, there was a mass mobilization campaign 
with a strong media presence and multi-sectoral involvement [6].  
The proportions of South Africans who have ever or recently sought HCT have increased. 
From 2005 to 2008, the proportion of South Africans who ever sought HCT increased from 31% 
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to 51%, and the proportion reporting tested in the last year climbed from 13% to 30% [7-8]. 
Although comparable statistics are not available from 2011, South Africa nearly reached its 
ambitious target of testing 15 million people during the 2010-2011 campaign [9], suggesting large 
increases in both the proportions of people ever tested and recently tested. 
Different models of HCT have been implemented in South Africa. Voluntary counseling 
and testing (VCT) is typically client-initiated and can be delivered in a health facility or 
community based venue [10]. Provider-initiated counseling and testing (PICT) is typically offered 
to all patients in clinics using an opt-out model, and was introduced in order to increase the 
volume of people aware of their HIV status. PICT has become common in antenatal settings, 
resulting in a higher proportion of women than men aware of their HIV status in South Africa and 
many other sub-Saharan African countries [11-13]. PICT models have also been introduced into 
other clinical settings, including tuberculosis, sexually transmitted infection, and outpatient [14-
16].  There have also been efforts to expand HCT through home-based, mobile, and workplace 
models in order to reach persons who do not attend clinics regularly [17-18].  
In all of these HCT models, there is often a group information session, and almost always 
an individual pre-test counseling session, the HIV test itself, and an individual post-test 
counseling session [19]. During the group session, modes of HIV acquisition and transmission are 
described, as well as HIV behavioral prevention measures. In the individual counseling sessions, 
these messages are reinforced and discussed in relation to the client’s personal risk factors. The 
HIV test typically consists of a serial rapid testing algorithm with results available on the same 
day. And in post-test counseling, different messages are given to HIV-infected and HIV-
uninfected clients. For those who are HIV-infected, there is discussion of methods for preventing 
onward sexual transmission of HIV, and for HIV-uninfected persons there are messages about 
preventing acquisition. Often, a patient commits to a behavioral plan. In VCT models, counseling 
tends to be longer and more intensive, as counselors tend to have more dedicated time than 
providers.  
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HCT is a necessary first step for linkage to care. However, understanding how best to 
leverage HCT for prevention purposes is less well understood. This dissertation addressed how 
HCT influences two very different populations in need of HIV prevention interventions: HIV-
discordant couples who are primarily in marital and cohabiting relationships and HIV-uninfected 
youth aged 15-24 living in a high prevalence region in South Africa.  
 
Populations at risk for HIV Acquisition 
 Aim 1 is conducted in a population of South African HIV-discordant couples. HIV-
discordant couples are important from a prevention perspective because the HIV-uninfected 
partner is at ongoing risk for HIV acquisition through sexual exposure to the HIV-infected partner 
[20]. In sub-Saharan Africa, there is considerable variation in the share of married and cohabiting 
couples that are HIV-discordant, with an estimated 1% in Niger and Senegal and 14% in Lesotho 
[21]. South Africa’s epidemic is more similar to Lesotho’s, suggesting its share of HIV-
discordant couples would be comparable to Lesotho’s [3]. 
 There is considerable debate over what share of total transmissions occur within married 
and cohabiting HIV-discordant couples in generalized epidemics. Estimates range from 14% to 
94% of all infections [22-23] with the share of total couples that are married and cohabiting being 
a key determinant [24]. Even if the fraction of new infections occurring in married and cohabiting 
relationships is on the lower end of the range, the absolute number of persons acquiring HIV from 
stable HIV-infected partners is substantial, given 1.8 million annual infections in sub-Saharan 
Africa [3]. Thus, interventions for these couples are important.  
 Couples HCT has long been recognized as an important intervention for HIV-discordant 
couples, and has been implemented in a variety of clinical and community settings in sub-Saharan 
Africa [25]. Recent guidance from the World Health Organization emphasizes the importance of 
couples HCT and other couple-oriented strategies [26] and offers suggestions on methods for 
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delivery. In spite of the numerous benefits and multiple delivery models, the majority of HCT is 
still conducted among individuals, not couples [26-27]. 
 Aim 2 is conducted in a population of HIV-uninfected youth living in a high prevalence 
sub-district of KwaZulu-Natal, South Africa. Youth, and especially young girls, are at very high 
risk for HIV acquisition throughout sub-Saharan Africa [3]. In South Africa, an estimated 21% of 
girls and 5% of boys acquire HIV by the time they are 24 years old [8, 28-29]. Although there is 
some indication that incidence rates are declining in South Africa [7], it is unclear if findings 
reflect a true decline or simply increasing rates of non-participation by HIV-infected youth.  
There are a variety of settings where youth 15-24 can get tested for HIV in South Africa. 
Youth over the age of 12 are able to test for HIV without adult consent [19]. As such, youth can 
be tested in antenatal and other clinical settings, stand alone HCT services, or home-based or 
mobile services. Nonetheless, South African youth report lower prevalence of HCT than adults 
[30]. 
There are important questions about how best to deliver HCT to youth. Delivering HCT 
in youth-appropriate ways is critical, as youth often report judgmental care-seeking environments, 
and this can be a barrier to care [31-32]. Stand-alone youth-only services are one option, but 
difficult to sustain at a national level. LoveLife, a South African organization dedicated to sexual 
health among young persons, has proposed a model for improving and then accrediting 
adolescent-friendly services in existing facilities, rather than creating stand-alone services [33]. 
This model has been shown to be effective at improving a variety of process indicators [34], but 
has not been evaluated for uptake of services or health outcomes. Schools are another possible 
venue for testing of youth. Demonstration projects have found a very high uptake of testing when 
it is offered in secondary schools, suggesting this may be an effective way of reaching a large 
volume of youth [35]. In 2011 South Africa announced its intention to introduce HCT into 
secondary schools [36], but this has not come into fruition due to controversy. There are concerns 
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about this environment being non-confidential, stigmatizing and deficient with respect to 
psychosocial support and linkage to care [36-37].  
 
HCT and HIV Incidence  
The effect of HCT on HIV prevention is surprisingly not well established. Randomized 
trials with HIV incidence endpoints are considered the gold standard for assessing the efficacy of 
HIV prevention interventions [38]. To date, there is only one randomized trial in sub-Saharan 
Africa assessing the efficacy of HCT with an HIV incidence endpoint [39]. In a cluster 
randomized trial in Zimbabwean workplaces, participants randomized to intensive on-site HCT 
were fifty percent more likely to acquire HIV than participants randomized to passive off-site 
HCT (Table 2.1). Although results were not statistically significant, the trend suggested HCT was 
not protective.  
A second randomized trial, HPTN 043 (Project Accept) randomized communities to 
either a multilevel HCT intervention (community-based mobile HCT, community mobilization, 
and posttest support services) or to standard clinic-based HCT [17, 27]. The study, which was 
conducted in South Africa, Zimbabwe, Tanzania, and Thailand, used community HIV incidence 
as the primary endpoint. Efficacy data have not been published yet, but early data show that 
uptake of HCT was much higher in intervention communities [17].  
In the absence of randomized trials, non-randomized observational studies with HIV 
incidence endpoints serve as an important source of evidence. In a large population-based study 
in Manicaland, Zimbabwe [40] those who received HCT were 30% more likely to acquire HIV 
than those who did not, although results were not statistically significant. In a large population-
based study in Rakai, Uganda [41] results were null and imprecise. In a clinic-based study in 
Kigali, Rwanda, incidence was slightly higher among HIV-negative women after HCT compared 
to before, although the effect was very small and not significant [42]. Although none of these 
studies had sufficient power to detect small effect sizes, all found that awareness of HIV status 
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was either non-protective with a trend towards elevated rates of HIV acquisition among HIV 
negative persons (Table 2.1). 
Additional observational studies with HIV incidence endpoints have compared those who 
test for HIV as couples to those who test for HIV as individuals. In Kigali, Rwanda, two years 
after HIV testing, those who accessed HCT with their partners experienced half the rate of HIV 
acquisition as those who accessed HCT individually [42-43]. This was the case among HIV-
negative women overall [43] and specifically among HIV-negative women in HIV-discordant 
relationships [42] (Table 2.1). This suggests that couples’ HCT may be more effective at reducing 
HIV incidence than individual HCT. 
Studies assessing the relationship between HCT and HIV acquisition have not been 
conducted among youth, and studies from adults cannot be readily extended to young persons. 
Understanding how HCT impacts HIV acquisition in this very high risk population is important.  
 
Associations between HCT and Sexual Behavior  
Behavioral endpoints are often used as intermediate measures for assessing the 
effectiveness of behavioral HIV prevention interventions. In assessments of the relationship 
between HCT and behavior change in SSA, there appears to be a marked contrast between 
persons who test HIV-negative and those who test HIV-positive [44]. Among those testing HIV-
negative, HCT does not appear to have an overall protective or harmful effect, though there is 
considerable variability between studies [10, 43, 45-47]. However, among those who test HIV-
positive, there is a consistent positive association with protective behaviors, especially condom 
use [44]. This has been seen in longitudinal studies within the same persons over time [45-46, 48-
50] and in cross sectional studies comparing aware persons to unaware persons [51-52]. These 
results are consistent with the results of studies with HIV incidence outcomes. 
In addition, several observational studies assessing the effect of HCT on behavior change 
have been conducted in HIV-discordant couples. In these couples, HCT has a very large effect on 
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self-reported condom use, an effect that exceeds what would be expected if both the HIV-positive 
and HIV-negative members of the couple tested separately [10, 42-44, 48, 53]. These effect sizes 
are consistent with, but more extreme than the results of studies with HIV incidence endpoints. 
The World Health Organization has recently released guidance emphasizing the importance of 
couples-based HCT strategies, and suggests several options for achieving these strategies [26].  
Although studies of HIV-discordant couples have large effect sizes, their generalizability 
has been questioned. Recruitment of couples has proven challenging in a number of clinical and 
research settings [45, 54-55] and those who participate may be more prevention-oriented. It is not 
known whether the large effect sizes would be seen in the general population. 
 
Conceptual Model 
Understanding why HCT may have little effect in HIV-negative persons, but a protective 
effect in HIV-positive persons and HIV-discordant couples is important. At the individual level 
the effect of HCT on sexual behavior and ultimately HIV incidence may be mediated by 
constructs in the “Information-Motivation-Behavioral Skills” (IMB) theoretical framework [56-
57].  This framework has been validated extensively in a number of settings, including South 
Africa, with HIV-positive and HIV-negative persons [57-60]. Within the context of HCT, 
information pertains to basic facts about HIV transmission and prevention, as well as information 
about one’s own and one’s partner’s HIV status. Motivation pertains to one’s desires to protect 
oneself or one’s partner from HIV, as well as one’s perception of the likelihood of HIV 
transmission or acquisition. Behavioral skills relate to one’s perceived ability (self-efficacy) or 
actual ability to perform risk reduction behaviors. These three IMB constructs can mediate or 
modify the adoption of a number of sexual behaviors (abstinence, condom use, pre-exposure 
prophylaxis use, partner reduction, sero-sorting) and care-seeking behaviors (circumcision and 
HAART for prevention) which could in turn affect rates of HIV transmission or acquisition 
(Figure 2.1). 
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HCT likely impacts IMB constructs differentially by HIV status. Learning that one is 
HIV-positive may increase one’s perceived risk of HIV transmission and motivate condom use 
[61]. On the other hand, learning that one is HIV-negative may lead to misperceptions about 
personal risk, such as perceived immunity [62], or the belief that one’s partner is also HIV-
negative. These misperceptions may lead to a decreased motivation to engage in protective 
behaviors and affirm past risk [63]. Mutual awareness of discordance may lead to the highest 
level of behavior change because the knowledge of HIV risk within the dyad is shared between 
both members of the couple as is the motivation to protect the uninfected partner. 
The AIDS Risk Reduction model (ARRM) is a second behavioral theory with direct 
applicability to the relationship between HCT and subsequent sexual risk [64]. ARRM postulates 
that HIV-related behavior change typically consists of three stages. The first, labeling, involves 
recognizing that one’s activities are putting them at risk for acquiring or HIV. The second, 
commitment, entails deciding to alter that risky behavior. The third, enactment entails making 
plans to overcome barriers to risky behaviors (such as communication with a partner) and 
learning strategies to reduce risky behaviors (such as correct condom use). The counseling 
portions of HCT sessions map directly onto these three stages.  
Additionally, these individual-level characteristics are embedded within a broader social 
ecology with dyad-level dynamics and larger social structures at play. In particular, the relative 
importance of these constructs may vary by gender [65-66] or age [67]. In South Africa, a society 
with wealth and power gaps between men and women [68], gender may be an important 
moderator of the relationship between HCT and HIV risk. In particular, a woman’s motivation to 
disclose her HIV status and subsequent self-efficacy to negotiate protective behaviors may be 
dampened by a fear of abandonment, blame, discrimination or violence [69-70]. Men’s 
motivation for risk reduction may be influenced by a fear of exposing unfaithful behaviors [71-
73]. Associations between HCT and these constructs may also differ by age. Adolescents are 
cognitively, emotionally, and behaviorally different from adults [74]. They also have different 
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types of sexual partnerships. For a variety of reasons, the age of marriage has been rising in South 
Africa and persons in the 15-24 age range are generally in unions of shorter duration than their 
older counterparts [75]. For all of these reasons, young persons may experience HCT differently 
than older persons.  
 
Innovation 
There are several key gaps in the understanding of HCT, sexual behavior, and HIV 
incidence. First, much of the research addressing these topics, especially research with HIV 
endpoints, was conducted when the care-seeking environment was quite different: HCT was less 
widely available and ART was largely unavailable. Second, studies conducted among HIV-
discordant couples did not account for how quickly after HCT condom use was adopted. Next, 
studies assessing the relationship between HCT and HIV incidence have not been conducted 
among young persons, and those conducted among adults had important design limitations [40, 
76]. Finally, there are several patterns of HIV status awareness within HIV-discordant couples 
that have not been well characterized. This dissertation addressed these gaps. I elaborate on them 
below. 
As the HIV care-seeking environment has evolved, the relationship between HCT and 
sexual behavior must be reassessed. The availability of treatment may alter the perceived severity 
of HIV. Such a change could lead HIV-negative persons to take fewer precautions to avoid HIV 
acquisition. Similarly, beliefs that those on HAART are less infectious could lead to behavioral 
disinhibition among HIV-positive persons and their sex partners. The relationship between 
HAART and disinhibition has been seen in developed countries [77], though it has not yet been 
seen in sub-Saharan Africa [78]. In Aims 1 and 2, the relationships between HCT and sexual 
behavior change were assessed in the era when HAART was being brought to scale. In Aim 1, 
this relationship was assessed among the HIV-positive index participants in HIV-discordant 
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couples [79]. In Aim 2, this relationship was assessed among HIV-uninfected youth aged 15-24 in 
a large demographic surveillance area [80].  
 The primary innovation of Aim 1 was the assessment of the impact of HCT on behavior 
change within HIV-discordant couples immediately after HCT. Couples HCT is associated with 
increased condom uptake [8-12]. However, timing of condom uptake is not well understood, 
because most studies did not have an assessment in the month after HCT. Thus behavior change 
could have taken several weeks or months to adopt. It is also not known whether those who 
continue engaging in unprotected sex engage in fewer unprotected acts. These questions, along 
with durability of condom use over a one-year period, were addressed in this aim.  
The primary innovation in Aim 2 is the assessment of the impact of HCT on HIV 
acquisition among young persons. Although the relationship between HCT and HIV acquisition 
has been assessed in adults, it has never been assessed in youth 15-24. HIV-uninfected adults who 
have received HCT have experienced equal or elevated rates of HIV acquisition compared to 
adults who have not [40-41]. Elevated infection among testers may be due to behavioral 
disinhibition among some high risk HIV-uninfected persons [47] or higher risk persons being 
more likely to seek testing. However, the implications of these findings are unclear for 
adolescents, who are cognitively, emotionally, and behaviorally different from adults [74]. 
Understanding how HCT impacts HIV in youth is essential, and may help inform ongoing 
discussions about whether, when, and how to offer HCT to young persons.  
Aim 2 also had novel design strengths that were not used in previous observational 
research. First, I used marginal structural models (MSMs) to account for time-varying 
confounders. This is particularly important when the exposure (HCT) in one time period 
influences confounders (e.g. sexual behavior) in a subsequent time period. In this context, MSMs 
allow for valid estimation of the exposure and outcome relationship, whereas traditional statistical 
methods may not [40-41]. Next, I formally correct for selection bias due to refusal. In large 
population-based sero-surveys HIV-positive persons aware of their HIV positive status are less 
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likely to participate [81-82]. This has the potential to lead to biased results if persons who were 
aware of their HIV status were more likely to sero-convert, but less likely to participate at later 
time points. I used inverse probability of censoring weights to account for this. Finally, none of 
the previous observational studies had sufficient power to detect the small differences in HIV 
incidence rates between exposure groups [39-41]. Given the large number of people in the 
catchment area, extremely high HIV incidence rates [83], and prevalence of HCT, I had sufficient 
power to detect smaller differences in incidence between HCT groups. Overall, these 
improvements produced results that were likely more valid and more reliable than previous 
observational estimates.  
In the third aim, a framework for considering several different patterns of HIV awareness 
was proposed in an Awareness Framework. This novel framework delineates all possible 
combinations of HCT and HIV status disclosure within HIV-discordant dyads. This is a 
descriptive aim that discusses how different types of HCT may result in different pattern mixes, 
and how these different pattern mixes may be associated with uptake of and adherence to 
behavioral and biomedical prevention.  
In summary, this dissertation offers four primary innovations. In Aims 1 and 2, questions 
about HCT and sexual behavior were revisited in a later time period. In Aim 1 the timing of 
condom uptake was explored. In Aim 2, the relationship between HCT and HIV acquisition were 
assessed in a younger population using more rigorous methods. And in Aim 3, a framework for a 
unified understanding of individual and mutual awareness of HIV status was proposed. Taken 
together, these three aims have contributed to ongoing discussions about what the prevention 
benefits of HCT are and how they might be optimized. 
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 Tables and Figures 
Table 2.1: Studies in sub-Saharan Africa Assessing HCT with HIV Endpoints 
Authors, 
Year 
Population/Setting Design/Exposures  Exposure/Intervention  Results Conclusions 
Testers versus non-testers  
Corbett et 
al., 2007[39] 
Harare, 
Zimbabwe 
Predominantly 
male workers 
(N=2996) 
2001-2004 
Cluster randomized 
trial in 22 
workplaces.  
 
HIV status 
ascertained at BL 
and at 2 years.  
Intensive: on-site rapid 
VCT (71% uptake) 
 
Standard: voucher for 
community-based VCT 
(5% uptake) 
Intensive: 1.37/100 
PYs;  
Standard: 0.95/100 
PYs 
Incidence rate 
ratio: 1.5 (0.8, 2.8) 
The group that 
tested had 
higher HIV 
acquisition 
rates, but not 
statistically 
significant   
Sherr et al., 
2006[40] 
Manicaland, 
Zimbabwe 
Adults in the 
general population 
(N=~10,000 PYs)   
1998-2003 
Prospective 
population-based 
cohort study 
 
HIV status 
ascertained from 
1998-2000 and then 
from 2001-2003 
Males 
Tested and given results 
(12%) 
Not tested (74%) 
 
Females  
Tested and given results 
(10%) 
Not tested (86%) 
 
*Results not reported 
for those tested who did 
not receive results 
Male w/ results: 
2.2/100 PYs 
Male non-testers: 
2.1/100 PYs 
Incidence rate 
ratio: 1.1(0.6, 3.8)  
 
Females w/ results: 
2.4/100 PYs 
Female non-
testers: 1.6/100 
PYs 
Incidence rate 
ratio: 1.6 (0.6, 3.8) 
 
Overall w/ results: 
2.3/100 PYs 
Overall w/o 
results: 1.8/100 
PYs 
Incidence rate 
ratio: 1.3 (0.8, 2.1) 
The group that 
got tested had 
higher HIV 
acquisition 
rates, but not 
statistically 
significant 
Matovu et 
al., 2005[41] 
Rakai, 
Uganda 
 
Adults in the 
general population  
(N=3158 people,    
 N=2631 PYs) 
1999-2000 
Prospective 
population-based 
cohort study 
Males  
VCT acceptors (62%) 
VCT non-acceptors 
(38%) 
 
Females 
VCT acceptors (62%) 
VCT-non-acceptors 
(38%) 
Male acceptors: 
1.5/100 PYs 
Male non-
acceptors: 
1.1/100PYs 
Incidence Rate 
Ratio: ~1.4 
 
Female acceptors: 
1.6/100 PYs 
Female non-
acceptors: 
1.7/100PYs 
Incidence Rate 
Ratio: ~0.9 
 
Overall acceptors: 
1.6/100 PYs 
Overall non-
acceptors: 
1.4/100PYs 
Incidence Rate 
Ratio: ~1.1 (p=0.6) 
The group that 
accepted 
testing had 
higher HIV 
acquisition 
rates, but not 
statistically 
significant 
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Matovu et 
al., 2007[75] 
Rakai, 
Uganda 
Adults in the 
general population 
in 2 or more annual 
surveys 
N=6637 
Prospective 
population-based 
cohort study 
Overall 
VCT repeat acceptors: 
24% 
VCT 1st acceptors: 40%  
VCT-non-acceptors: 
36% 
Overall 
VCT repeat 
acceptors:1.4/100 
PYs 
VCT 1st acceptors: 
1.6/100 PYs 
VCT-non-
acceptors: 1.6/100 
PYs 
Incidence Rate 
Ratio: 1.0  
Repeat 
acceptors 
seemed 
slightly 
protected 
compared to 
first time-
acceptors or 
non-acceptors. 
Results were 
not significant. 
Individual testers versus couple testers  
Allen et al., 
1992[42] 
Kigali 
Rwanda 
N=945 HIV-
negative women 
Followed from 
Pre:1986-1988 
Post: 1988-1990 
Prospective cohort 
study with a pre-
post and exposed/ 
unexposed groups 
 
Females 
Tested individually: 
667 
Tested with partner: 
278 
 
Individually aware  
Pre:2.8/100 PYs, 
Post:2.9/100 PYs 
 
Mutually aware 
Pre:4.2/100PYs, 
Post:1.4/100PYs  
 
Incidence rate ratio 
(post): 0.5 
 
The group that 
tested in a 
couple had a 
significantly 
lower 
acquisition 
rate. 
Allen et al., 
1992[43] 
Kigali, 
Rwanda 
Women seeking 
ANC who tested 
HIV-negative 
individually or with 
HIV-positive male 
partner followed 
for 2.2 years. 
 
Prospective cohort 
study with 
modeling 
component. 
Proportion of HIV-
negative women 
testing individually 
who were in HIV-
discordant couples 
was modeled. 
Females 
Tested individually: 
1160 PYs 
Tested with partner: 
~60 PYs 
 
Individually aware 
probable 
discordant couples: 
22/100 PYs 
 
Mutually aware 
discordant couples: 
9/100 PYs 
Incidence Rate 
Ratio: 0.4 
The group that 
tested 
individually 
had 
presumably 
higher HIV 
acquisition 
rates. Results 
were not 
significant. 
 
Caption: Table 2.1 summarizes completed studies in sub-Saharan Africa of HCT with HIV 
endpoints.  
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Figure 2.1: Information, Motivation, Behavioral Skills Theoretical Framework 
 
 
 
Caption: Figure 2.1 depicts how the Information-Motivation-Behavioral Change theory 
relates HIV counseling and testing to HIV prevention. 
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CHAPTER III: Resarch Design and Methods 
 
The study designs, study populations, exposure and outcome assessments, and statistical 
methods for aims 1 and 2 were distinct. In this chapter, I describe the entire approach for Aim 1 
before proceeding to the approach for Aim 2. Since the third aim is not data-driven, this approach 
is described only briefly. 
 
Aim 1 
Study Design: 
In the first Aim I assessed whether awareness of being HIV-positive was associated with less 
unprotected sex in HIV-discordant couples. This aim relied on behavioral data from the Partners 
in Prevention HSV/ HIV Transmission Study (PIP) conducted among HIV-discordant couples in 
sub-Saharan Africa. PIP was a Phase III randomized placebo controlled trial. It was designed to 
assess the effect of acyclovir taken daily by HIV-1/HSV-2 co-infected “index participants” on 
disease progression [1] and HIV-1 transmission to HIV-uninfected sex “partners” [2]. HIV-
infected index participants in both the intervention and placebo groups were seen monthly to 
receive intervention or placebo tablets, condoms, and counseling. In addition, at monthly visits, 
biomarkers were collected and index participants were assessed for sexual behavior in the 
previous month.  
 The underlying research question in Aim 1 is whether HIV-positive persons who know 
their HIV status are less likely to have unprotected sex than HIV-positive persons who do not 
know their HIV status. In observational analysis, this is typically assessed through comparisons 
of sexual behavior in the same persons before and after learning their HIV status, or through 
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comparisons of sexual behavior in persons who do and do not know their HIV status. Because 
everyone in PIP was aware of their HIV status at baseline, neither of these comparisons is 
possible. However, many participants had learned their HIV status in the month preceding 
baseline (<30 days), and some of these participants had even learned their HIV status in the week 
preceding baseline (<7 days). Therefore some participants were aware of their HIV status for only 
a small part of the previous month (<7 days) and others had been aware of their HIV status for the 
entire previous month (>30 days). For participants aware for the entire previous month, all 
reported sexual activity must have occurred after learning their HIV status. For participants 
recently aware, some sexual activity may have occurred before learning their HIV status. This 
baseline comparison was used to approximate the comparison between persons who do and do 
not know their HIV status. Comparisons of self-reported sexual behavior at baseline with self-
reported behavior afterwards approximate the comparison of the same persons before and after 
learning their HIV status.  
 The primary analysis compared those who learned their HIV status <7 days before 
baseline to those who learned their HIV status >30 days before baseline. I assessed whether the 
recently aware group was more likely to report unprotected sex and a higher relative number of 
unprotected sex acts in the last month at baseline, month one, month six, and month twelve 
(Figure 3.1). One strength of this analysis was that it allowed for comparisons between groups at 
each point in time, as well as a comparison within each group over time. The baseline comparison 
was included to compare those aware for the full month to those aware for part of the month. The 
month-one comparisons were included to compare whether behavior change in both groups 
occurred immediately. The six and twelve month comparisons were used to assess whether 
behavior change in each group was maintained over time. 
 At the baseline cross section, I also conducted a sensitivity analysis on the time since HCT 
cut-point. In addition to comparing sexual behavior among persons tested >30 days before 
baseline to persons tested <7 days before baseline, I also compared sexual behavior among 
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persons tested >30 days before baseline to persons tested 8-14 days before baseline and persons 
tested 21-30 days before baseline. These additional comparisons allowed for assessments of 
whether there was a dose-response relationship between the amount of time someone was 
unaware of their HIV status and both the odds of unprotected sex and relative number of 
unprotected sex. If awareness was protective, persons aware for less time (e.g. 7 days) would be 
more likely to report any unprotected sex and more likely to report more unprotected sex acts 
than those aware for more time (i.e. 8-14 or  15-30 days) (Figure 3.2). 
 This study addressed a question that was similar to questions from previous behavioral 
research among HIV-discordant couples [3-7]. However, previous studies were conducted prior 
to the scale-up of treatment, whereas PIP was conducted from 2004-2008, when HAART was 
being brought to scale. This context could have altered the motivation to change behavior, if 
availability of treatment altered the perceived severity of HIV acquisition. In addition, this was 
the first study to be conducted in South Africa, which is often characterized by union instability 
[8]. Findings may have differed in this social context. Findings from this study were qualitatively 
compared to the findings of previous work conducted at early time periods in other parts of SSA. 
 
Study Population 
 The entire PIP trial enrolled 3408 couples from 14 sites in seven sub-Saharan African 
countries. This analysis relied on data from 508 HIV-infected index participants enrolled from 
2004-2007 at the three South African sites: Gugulethu, Orange Farm, and Soweto. Each couple 
was followed for 12-24 months between November 2004 and October 2008.  
 All three sites are situated in populous areas with predominantly black inhabitants. 
Gugulethu is a township located 10 miles outside of Cape Town with a population of 340,000. 
Orange Farm is a township located 30 miles outside of Johannesburg with a population of 
500,000. Soweto is a lower middle class urban part of the city of Johannesburg with a population 
of 1.2 million. The adult HIV prevalence in all three sites is high: 27% in Gugulethu and 30% in 
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both Orange Farm and Soweto [9]. At all three sites, ARV rollout began prior to the beginning of 
the study period [10-12].  
 
Recruitment  
 Recruitment and initial screening for the study were conducted using individual and 
couples HCT in both HIV testing and HIV clinical facilities at all three sites. In the larger study 
51,900 couples were screened. The prevalence of HIV-discordance at the three South African 
sites was 31% at Gugulethu, 28% at Orange Farm, and 23% at Soweto [9].  
 
Eligibility 
Of those who were screened and identified as HIV-discordant, 48% (N=3135) did not meet study 
eligibility criteria or decided not to enroll. The eligibility criteria are listed below, along with the 
proportion of couples ineligible for each reason. 
 The HIV-positive index participant had a CD4 count >250 (54%) 
 The HIV-positive index participant had an AIDS-defining illness (2%) 
 The HIV-positive index participant was HSV-2 sero-positive (14%) 
 The couple had been sexually inactive for the previous three months or likely to 
terminate the relationship in the next 24 months (5%) 
      In addition, 20% of couples did not participate for other reasons.[13]  
 At the three South African sites, three quarters of index participants were female, a 
fraction that reflects the higher prevalence of HIV among women in South Africa and the higher 
rates of testing among women [14-15]. The mean age was 33 years (SD=8.5) and the mean 
education level was 9.4 years (SD=2.8). The majority of indexes (82%) had at least one child. 
Few (<5%) reported more than one sex partner in the last month. One third of couples were 
neither married nor cohabitating, half were not married but were cohabitating, and 16% were both 
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married and cohabitating. The average relationship length was 4.4 years (SD=5.1). On average, 
males were 4.1 (SD=6.4) years older than females, regardless of which partner was HIV-positive. 
Few indexes reported relationship violence in the last month.   
 A small minority of South African index participants (<1%) enrolled with two HIV-
uninfected partners. For this analysis, only the sexual behavior pertaining to the first enrolled 
partner was analyzed. If a second partner was enrolled, this person was categorized as an 
additional sexual partner, along with other additional reported partners. 
 
External Validity 
 The recruitment procedures and eligibility criteria lead to several questions about the 
generalizability of the study population. First, persons who presented for testing as couples may 
have differed from persons who presented individually or did not present at all. They reflect a 
subset of the population in which both members of the partnership were willing to learn their own 
results and disclose their results to one another. In a society that has been characterized by male-
dominated decision-making and high rates of partner violence [16-18], this may reflect a subset 
of couples where power is shared more equitably. The very low baseline rates of reported partner 
violence suggested that this may be the case [19]. They may also reflect couples in which one or 
both members had previous consecutive or concurrent partnerships but not current concurrent 
partnerships at the time of enrollment. In addition, couples in the study population may have been 
more stable than couples in the general population. The fact that all were willing to enroll for a 
two-year period and almost all were married or cohabitating supports this notion as there have 
been documented declines in marriage and cohabitation in the South African social structure [20]. 
Finally, because of the CD4 and disease progression eligibility criteria, these couples represented 
persons at an earlier stage of HIV natural history.  
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Exposure Assessment 
The primary exposure for aim 1 is time since diagnosis dichotomized as those who learned their 
HIV status <7 before baseline versus those tested >30 days before baseline. Two other categories 
were also explored: persons tested 8-14 and 15-30 days before baseline. At baseline, the three 
groups that reported <30 days could have had unprotected sex before they were aware of their 
HIV status. Those diagnosed >30 days before baseline could have only unprotected sex only after 
they were aware of their HIV status.  Among all of the indexes, the median time since diagnosis 
was 29 days (IQR: 11 days, 9.2 months).  
 
Outcome Assessment 
Unprotected sex was characterized based on index self-report at baseline and then every 
month thereafter. In this analysis, data is used from four of those time points: baseline and months 
one, six, and twelve. At each time point, indexes were first asked how many times they had sex 
with their study partner in the last month. If indexes reported at least one act, they were then 
asked how many times a condom was used. From these questions, the primary outcome was 
determined: a) whether or not the index had any unprotected sex in the past month and b) the 
number of unprotected sex acts in the past month. These two behavioral endpoints were selected 
because they determined whether and how often a partner was exposed to HIV, the measures of 
greatest public health relevance. In addition to these primary outcomes, I calculated whether or 
not participants had any sex acts at all with their study partner in the past month. 
For previously diagnosed indexes (>30 days before baseline), all unprotected sex acts 
reported at baseline must have occurred after becoming aware of their HIV status. For recently 
diagnosed indexes (<7, 8-14, and 15-30 days before baseline) unprotected sex occurred either 
before or soon after becoming aware of their HIV status. At the one, six, and twelve-month time 
periods, all unprotected sex acts in both groups occurred after diagnosis. 
 
33 
 
33 
 
Information Bias 
Although the larger trial was prospective, this particular analysis ascertained information 
about the exposure and the outcome retrospectively. It is possible that this would lead to 
differential misclassification [21]. At enrollment, those who knew their HIV status for the entire 
previous month may have been less likely to report any unprotected sex in that last month (i.e. 
higher social desirability). This could have biased results away from the null.  
 
Statistical Analyses  
The first set of analyses was longitudinal. I compared recently and previously diagnosed 
indexes at four time points: baseline, month one, month six, and month twelve. Generalized 
estimating equations with robust variance estimators were used to account for within-subject 
clustering at the three different time points. Robust variance estimates accounted for within 
cluster correlation. An exchangeable correlation matrix was specified for within-subject 
correlation. An exchangeable correlation matrix assumes that correlations within the same 
subject, but between different time periods, are equal. This assumption is justifiable in settings 
where variation between subjects is expected to be stronger than variation within subjects, an 
assumption that is typically justifiable in repeated measures studies [22]. 
Two types of models corresponding to the two main outcomes (binary and continuous) 
were used. The first compared the odds of unprotected sex in the last month at each time point. 
For this outcome, I used a generalized linear model with a logit link and a binomial distribution. 
This specification of a generalized linear model provided an estimate of the odds ratio at each 
cross section. The second model compared the relative number of unprotected sex acts in the last 
month at each time point. To compare the relative number of acts between the two groups, I used 
a generalized linear model with a log link and a negative binomial distribution. This specification 
of a generalized linear model provided a direct estimate of the relative number of events at each 
cross section.  
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Informal exploratory assessments of the data suggested that the frequency of unprotected 
sex was over-dispersed (i.e. the conditional mean was smaller than the conditional variance), 
suggesting a negative binomial model would be the better fit for the data. Since Poisson models 
are nested within negative binomial models, a likelihood ratio test (LRT) comparing the negative 
binomial model to the Poisson model was used to compare this relationship formally. In this 
setting, an LRT compares the hypothesis that the dispersion term in the negative binomial model 
leads to no improvement in model fit over the Poisson model. Rejecting the null hypothesis 
implies the dispersion term is necessary and the data are over-dispersed.  
In both unadjusted models, I included a variable for the main exposure (aware), an 
indicator for month one, six and twelve time periods, and interaction terms between the main 
exposure and each of the two later time periods. These equations can be expressed as follows: 
 
[1] Ln[Pr(Y)]  =α + β1Xaware + β2Xtime1  + β3Xtime6  + β4Xtime12 + β5Xaware*time1 + β6Xaware*time6 + 
β7Xaware*time12 
 
[2] Ln[Count(Y)] = =α + β1Xaware + β2Xtime1  + β3Xtime6  + β4Xtime12 + β5Xaware*time1 + β6Xaware*time6 + 
β7Xaware*time12+ γover-dispersion  
 
I also conducted a baseline cross sectional analysis to assess whether those more recently 
diagnosed were more likely to report any unprotected sex at baseline. Preliminary inspection of 
the data suggested that zero-inflated models would be needed for the baseline data to account for 
the high proportion of participants reporting zero unprotected sex acts in the last month. I first 
compared Poisson and negative binomial (NB) regression models using a likelihood ratio test. I 
then compared the better of these two models to a Zero-inflated model using a Vuong test for 
non-nested models[23]. Graphical comparisons of the predicted probabilities were also used to 
assess which model was the best fit for the data.  
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Zero-inflated models are used when it is expected that data are generated from two 
separate processes: one that generates only zeroes (i.e. no unprotected sex), and another that 
generates a count (i.e. some number of unprotected sex acts). Zero-inflated NB and Poisson 
models provided a parsimonious and powerful way of modeling both processes at once. By 
solving two simultaneous equations, these models generated two sets of parameter estimates. The 
first set was generated using a logistic regression procedure. This set was used to compare the 
odds of zero unprotected sex acts between the two exposure groups. The second set of parameters 
was generated using a NB regression procedure. This procedure was used to compare the relative 
number of unprotected sex acts between the two exposure groups.  
In both the longitudinal and cross sectional models direct acyclic graphs (DAGs) were 
used to identify individual and couple characteristics that could confound the association between 
time since diagnosis and unprotected sex [24]. The individual-level variables were gender, age, 
education level, parity, and having had more than one sex partner in the previous month. The 
couple-level variables were marital and cohabitation status, relationship length, relationship 
violence in the last three months, and male-female age difference. All of these variables have 
been shown to be associated with HIV testing, sexual behavior, or both, in multiple studies in 
sub-Saharan Africa.  
 For both the longitudinal and cross-sectional models, interaction between the main 
exposure and key covariates of public health relevance (gender, age, and site) were assessed prior 
to confounding. Maximum likelihood methods were used to assess whether an interaction term 
led to a significantly greater model fit at an alpha level of 0.1. 
All variables that were not considered interaction terms were then assessed for 
confounding. To determine which variables to include in the final multivariate model a backward 
elimination change-in-estimate process was used. I started with all covariates described above 
and assessed the resulting change in estimate of the main exposure. Covariates were retained if 
estimates on the log scale changed by more than 10%. Covariates least likely to result in 
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confounding were removed first. This order was determined by bi-variable exploratory analyses 
and subject matter knowledge. All analyses were conducted in SAS v.9.2. (SAS Institute, Cary, 
North Carolina).  
 
Aim 2 
Study Design 
In the second aim, I assessed whether HIV-negative youth who received HCT were more 
likely to acquire HIV than HIV-negative youth who did not receive HCT. For this aim I used data 
from a demographic surveillance system collected by The Africa Centre for Health and 
Population Studies in KwaZulu-Natal, South Africa. When the Africa Centre Demographic 
Information System (ACDIS) was initiated in 2000, primarily demographic, social, and health 
indicators were collected [25]. Starting in 2003, a sero-survey, that included HIV status, was 
collected on an annual basis. These annual assessments have continued until the present.  
One challenge for studying the relationship between HCT and HIV acquisition is that the 
exposure and the outcome both involve HIV testing. For meaningful analysis, it is essential that 
all participants have been tested for HIV (so outcome information is available), even though some 
participants do not know their own HIV test results (so different exposure statuses can be 
compared). In this analysis, the exposure and outcome were ascertained through separate 
mechanisms. The primary exposure (whether or not someone sought HCT outside of the survey) 
was be ascertained by behavioral self-report. The primary outcome (HIV acquisition), was 
ascertained from blood provided for the ACDIS sero-survey. ACDIS participants who provided 
blood for the sero-survey did not learn their HIV status through survey participation during the 
study period. Rather, participants were encouraged to seek free HCT in the community to learn 
their status.  
The current analysis built upon the strengths of ACDIS and the sero-survey. First the 
sero-survey was longitudinal, allowing for the temporal observation of HIV testing and HIV 
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acquisition. Second, the cohort was large and the HIV incidence rate was one of the highest in the 
world [26-27]. HIV incidence rates allowed for a sufficient sample size to detect even small 
differences between exposure groups. Third, the methods for ascertaining HCT (self-report) were 
distinct from the methods for ascertaining HIV status within the survey (laboratory-based 
antibody assays without return of results). These distinct methods for ascertaining exposure and 
outcome information were essential for this analysis as HIV status was available even for persons 
who had never received HCT. Finally, the dataset had a rich set of covariates collected at multiple 
time points which allowed for control of time-varying confounding [28].  
 
Study Population 
ACDIS contains information from a demographic surveillance area located in the 
Umkanyakude district in northern KwaZulu-Natal, South Africa (Figure 3) [25]. The area is 435 
square kilometers and predominantly rural, though it contains an urban township and informal 
peri-urban settlements [28]. The area houses approximately 86,000 residents and non-residents 
[25] who are primarily Zulu-speaking [28].  
Nested within ACDIS is the population-based HIV sero-survey that contains information 
about participants’ knowledge, attitudes, and sexual behaviors; care seeking behaviors; and 
knowledge and beliefs about antiretroviral therapy. In addition, everyone was asked to provide a 
blood sample for laboratory-based HIV testing. Before 2007, there was an age eligibility 
requirement of 15-49 for women and 15-54 for men. However, starting in 2007, all persons over 
15 were eligible to participate [25].  
The catchment area is hard-hit by the HIV epidemic. The 2004 adult HIV prevalence was 
estimated to be 13.5% in adult men and 26.8% in adult women [27], although a reanalysis of 
these data suggest that these are underestimates [29]. The rate of new infections also remains high 
with a relatively constant annual HIV incidence of 3.4 per 100 person-years (95% CI: 3.1, 3.7) 
between 2003 and 2007, although this rate differs considerably by age and gender [26]. Assuming 
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constant prevalence and the absence of a competing risk of death, the cumulative risk of infection 
is 74% for women by age 49 and 78% for men by age 54 [30].  
 
HCT in the Subdistrict  
 The community has had access to several different forms of HCT outside of the ACDIS 
sero-survey. Since 2000, HCT was available in the district hospital. In order to support 
decentralized rollout of ART in the catchment area, HCT was introduced into all of the primary 
health centers beginning in 2004-2005 [31]. Counselors provided HCT service both to clients 
who presented specifically for HCT and to patients who were referred from other clinical services 
(tuberculosis, STI, and ANC) [32]. During the national HCT campaign from 2010-2011, the 
nature of these services did not change, but the volume of services increased. HCT was offered to 
all persons over 12 presenting to the primary health clinics. Although provider referral is quite 
common, provider-initiated testing is rare. Almost all testing is performed by counselors.  
 There are other forms of HCT in the catchment area, as well. Private outpatient clinics, 
and the district hospital also offer HCT. In addition a local NGO offers HCT in some secondary 
schools and the President’s Emergency Plan for AIDS Relief has supported the Africa Centre to 
implement home-based HCT and community-based HCT in remote parts of the catchment area 
starting in 2008-2009 [33].  
 Starting in 2010, there was a question on the sero-survey about where persons had 
sought HCT. Of 2771 youth who responded to this question in 2010, 54% reported that it was in a 
primary health clinic, 20% reported that it was through home-based testing, 7% reported mobile 
testing, 3% reported a private clinic, 3% reported in the hospital, and 13% reported other. Many 
of the “other” responses were the specific names clinics or physicians in the catchment area.  
 There has been a steady increase in HCT over time among youth in the catchment area. 
The proportion of youth 15-24 who were aware of their HIV status from HCT increased from 
27% in 2007 to 52% in 2009 to 59% in 2011 [34]. In 2011, females were 1.9 (95% CI: 1.8, 2.1) 
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times as likely as males to be aware of their HIV status and youth were 7.2% (95% CI: 6.2%, 
8.2%) more likely to be aware of their HIV status with each one year increase in age (< 16 
years=41%, 24 years: 76%). Persons who were HIV-infected were 1.3 (95% CI: 1.2, 1.4) times as 
likely to be aware of their HIV status as HIV-uninfected persons, but this effect was negligible 
after adjustment for age and gender (prevalence ratio: 1.0, 95% CI 0.9, 1.0). 
 
Eligibility for the Current Analysis 
To be included in this analysis, persons must have met the following eligibility criteria:  
 Was a resident in the ACDIS demographic surveillance area or a randomly selected non-
resident who participated in ACDIS. 
 Participated in the sero-survey at least two times between 2006 and 2010. 
 Reported whether or not they had received HCT in at least two sero-survey rounds. The 
first report had to be no HCT, the second report could be either HCT or no HCT. 
 Tested HIV-negative in at least one sero-survey before the baseline time point and then 
tested again (either HIV-negative or HIV-positive) in at least one subsequent sero-survey 
round after the baseline time point. 
 Was 15-24 years old at the time of their first report of HCT. 
 
Recruitment 
Fieldworkers make rigorous attempts to contact all persons in the catchment area. For 
each survey round, teams of two trained fieldworkers visit eligible persons in their households. If 
they are not present at the first attempt, they are re-contacted up to three additional times. For 
subjects who moved from one time period to another, up to ten attempts are made to find the 
individual at the new place of residence, including outside the catchment area [28].  
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Participation in the Risk Set 
When conducting time-to-event analysis, the choice of a time scale is important, as the 
model implicitly adjusts for time on that time scale [35-36]. Regardless of which time scale is 
selected, the total person time and the total number of events are the same. However, the risk sets 
at each event time are different. This can lead to different persons being compared to one another. 
A graphical depiction of this is presented in Figure 3.2.   
The primary time scale that I used in this analysis was time since HCT. This was selected 
as the primary time scale since because it relates directly to the research question. I also explored 
time on study as a sensitivity analysis [36]. Other time scales, including age, time since 2006, and 
time since sexual debut were controlled for analytically.  
Given the dynamic nature of the cohort there was the potential for late entries (i.e. people 
entering the study after their origin) on most time scales. By requiring that persons report not 
receiving HCT at the first time point, it was possible to estimate the time when they did get HCT. 
Persons were at risk for HIV acquisition from the time they entered the risk set until the time they 
acquired HIV or were administratively censored due to reaching the end of the follow-up period 
(2011), refusal, or leaving the cohort through death, out-migration or incarceration.  
 
Internal Validity 
The number of eligible residents was approximately 25,000 in the first three rounds of 
survey collection. Of those eligible, the proportion contacted was 77% in 2003/2004, 98% in 
2005, and 92% in 2006. And of those contacted, the proportion who consented to testing within 
the ACDIS sero-survey was 58% in 2003/2004, 41% in 2005, and 38% in 2006. (Exact numbers 
are not published from 2007-2010, though 2006 numbers can be used as a proxy).
1
  
The high proportion of missing data from the ACDIS sero-survey raises concerns about 
validity due to selection bias. Selection bias takes the structural form shown in Figure 3.3 [37], 
                                                 
1
 This is based on personal communication with investigators. 
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conditioning on a common effect. In this example, HCT is the exposure, observed HIV 
acquisition in the ACDIS sero-survey is the outcome, and participation in the ACDIS sero-survey 
is a form of conditioning (i.e. restriction).  
Those who sought HCT and learned they were HIV-positive may have been less inclined 
to participate in the sero-survey than those who sought HCT and learned they were HIV-negative 
or those who never sought HCT. These associations have been seen in sero-surveys in other 
populations and lead to underestimates of HIV prevalence [38]. However, our study looked at 
HIV incidence.  
 
Exposure Assessment 
In Aim 2, the primary exposure was whether or not someone received HCT and learned 
their HIV results outside of the ACDIS sero-survey. This exposure was based on behavioral self-
report collected in the ACDIS sero-survey from 2006-2010. Table 3.1 displays  the items 
included in the individual questionnaire, the response options, and the periods when each 
question was asked. For this analysis the following question was used: “Do you know your HIV 
status from previous testing?”  
Because the response to this question may change over time, this exposure is time-
varying and each participant could contribute person-time to either or both exposure groups. All 
participants who report HCT at the time of their first visit were considered “exposed” for the 
entire follow-up period. All participants who did not report HCT during any of their follow-up 
periods were considered “unexposed.” All participants who reported HCT at some point during 
follow-up have their person-time split between two exposure groups. The primary exposure was 
estimated based on the timing of the first HIV test in the following way:  
 For participants who reported not knowing their HIV status from previous testing in their 
first survey round and knowing their HIV status from previous testing in the second 
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survey round, the estimated date of first test was calculated as the midpoint between these 
two survey dates.  
 For participants who reported knowing their HIV status “from previous testing” at a 
subsequent survey round, the date of first test was calculated as the midpoint between the 
date of the previous survey round and the subsequent survey round. The person-time 
contributed before the date of the first test was considered “unexposed” and the time after 
was considered “exposed.” 
 Participants who never reported having HCT were considered “unexposed” for the entire 
study duration. Their time started at the midpoint between their first two reports of not 
knowing their HIV status.  
 
In this analysis, there was potential for exposure misclassification resulting from 
behavioral self-report. In a validation sub-study of HIV awareness in the Kenya AIDS Indicator 
Survey, 44% of HIV-positive respondents reported knowing their HIV status. However, of these, 
the majority believed that they were HIV-negative [39]. This could have been attributed to 
receiving an HIV-negative test result prior to HIV sero-conversion. However, it could also stem 
from denial, social desirability, recall error, misunderstanding of the question, or misperceived 
HIV status. The possibility of information bias was a concern in this analysis, as well, although in 
our case the question about HCT exposure was asked among persons when they were HIV-
uninfected.  
 
Outcome Assessment  
In Aim 2, the primary outcome was HIV acquisition. HIV acquisition was determined by 
one negative HIV test result followed by one subsequent positive HIV test result. The timing of 
the HIV acquisition event was calculated as the midpoint between the date when the last HIV test 
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was negative and the first HIV test was positive, minus 30 days. The reason for subtracting 30 
days is to allow for a window period between the time HIV was acquired and detected [40]. 
For consenting participants, blood was obtained via finger prick and prepared into dried 
blood spots. A serial HIV testing algorithm with two ELISAs is used: Vironostika HIV-1/HIV-2 
Microelisa System (Biomérieux, Durham, NC, USA), followed by Wellcozyme HIV 1+2 
GACELISA (Murex Diagnostics, Benelux B.V., Breukelen, The Netherlands) [25]. 
 
Temporality of Exposure and Outcome 
Because the dataset was interval censored, some persons reported HCT and acquired HIV 
during the same survey round. When this occurred, the change in outcome always preceded the 
change in exposure. This is a function of the exposure being classified as the midpoint between 
two HIV tests and the outcome being classified as the midpoint between two HIV tests, minus 
one month. This classification helped to avoid a reverse causality problem. A sensitivity analysis 
was conducted to determine the degree to which this might be biasing the results. 
 
Statistical Analyses 
The purpose of the statistical analysis was to compare the hazard of HIV acquisition 
among those exposed to HCT to those unexposed to HCT. I first explored descriptive 
relationships in the data. I calculated the crude incidence rates within each exposure group and 
calculated a crude hazard ratio. I informally examined plots of the hazards as a function of each 
time scale to assess whether hazards were constant over time and hazard ratios were proportional 
over time. An interaction term with time was assessed formally using a likelihood ratio test. The 
model with the interaction term can be expressed as follows. 
 
 [3] hi(t)= ho(t)*e
β1HCT + β2HCT*time  
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Addressing Confounding  
         There were several socio-economic and behavioral covariates that were explored as 
potential modifiers and confounders of the relationship between HCT and HIV acquisition. Age 
and gender were explored as potential modifiers and included if they differed at an alpha level of 
0.1. Otherwise they were to be included as confounders. Other confounders included in the 
analysis were education, whether sexual debut had occurred, whether a woman had ever been 
pregnant or a man had ever fathered a child, number of sexual partners in the last year, and 
condoms us at last sex.  
         Because this analysis included time-varying covariates whose values in one time period 
were potentially affected by their exposures in a previous time period, traditional statistical 
methods could not be used. Marginal structural models were needed [41]. In marginal structural 
models, a pseudo-population was created by using inverse probability of exposure weights, which 
are estimated similarly to propensity scores and amount to a parametric standardization of the 
data [42].  
 
Accounting for Selection Bias 
 As described earlier, I explored the data for informative selection and attempted to correct for it. 
The directed acyclic graph in Figure 3.3 shows the structure of selection bias in this analysis. One 
frequently used set of criteria for informative selection are 1) that the proportion not participating 
is substantial, 2) that participation is associated with the exposure (HCT) and 3) that participation 
is associated with the outcome (HIV status) [37].  
The first criterion is met. Approximately half of those eligible for the sero-survey refused 
to provide a sample in the ACDIS sero-survey at each time point [25]. For the second criterion, it 
was possible to assess the relationship between participation and prior HCT. This is because there 
were many persons who participated in ACDIS and answer questions about previous HIV testing, 
but refused to provide blood for HIV testing. For the third criterion, it was possible to assess 
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whether participation was associated with HIV status. This can be done by exploring whether 
those found to be HIV positive in one time period were more or less likely to participate in a 
subsequent time period, especially those who knew their HIV status. This type of assessment was 
conducted in a Malawian longitudinal cohort. It was found that persons who were HIV-positive 
and knew their HIV status were four times less likely to participate than those who were HIV-
negative and knew their status [43-44]. Research in this cohort suggests that those who refused to 
be tested for HIV were more likely to die than those who did not [29]. This suggests that 
participation is associated with the outcome. However, given that all persons in this analysis 
started out HIV-uninfected, death from AIDS was unlikely during the follow-up period, even 
among persons who may have acquired HIV.  
Refusal was a more plausible source of selection bias. We addressed loss to follow-up by 
refusal through inverse probability weighting (IPW). This method assigns a weight to each 
selected subject so they account not only for themselves but also for missing participants with 
similar covariate patterns. For example, if five members of the study with a common covariate 
pattern are eligible for the sero-survey and two of these five (2/5) refused, the remaining three 
(3/5) would have an inverse probability weight of 5/3. This process results in a pseudo-population 
in which the two subjects who were lost are replaced by the three who remain [37]. This method 
was feasible in this cohort, as there was rich covariate information for many who did participate 
in ACDIS, but did not participate in the sero-survey. It is worth pointing out that IPW requires a 
missing at random (MAR) assumption. Thus, if true HIV-status influences participation or is 
associated with unknown or unmeasured covariates, this would result in biased estimation of the 
outcome. If those who participate are sound representations of those who are lost, then this 
method is sufficient.  
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Power and Sample Size 
In this analysis, the working hypothesis was that HCT leads to a modest increase in HIV 
acquisition. A priori I assessed how much power there would be to detect hazard ratios ranging 
from 1 to 1.5 within each strata of gender. The cohort is dynamic with participants constantly 
entering and leaving. However, it was reasonable to assume that 8000 participants would meet 
eligibility criteria and contribute four years of person time from 2006-2010 [25]. Next, I assumed 
that the hazard of HIV acquisition was constant across time. Finally, I assumed that the number 
exposed and unexposed to HCT were equal. This was realistic because in the earlier years, most 
participants were “unexposed” to HCT and in later years, most participants were “exposed” to 
HCT. This assumption was varied to assess whether power calculations were sensitive to group 
sizes.  
Looking at the entire population of men and women together, when the reference hazard 
was 2.5 per 100 person-years, there was 91% power to detect a hazard ratio of 1.25. If there were 
twice as many participants in the exposed or unexposed groups, there was still at least 85% power 
to detect a hazard ratio of 1.25.   
Figure 3.5 displays the amount of power available to detect hazard ratios form 1 to 1.5 
assuming reference hazard levels of 2, 2.5, and 3 sero-conversions per 100 person years. If the 
reference hazard were 3 per 100 person years (which is likely for women) there would be 83% 
power to detect a hazard ratio of 1.30 and 92% power to detect a hazard ratio of 1.35. Holding the 
number of people constant, but varying the amount of person-time in each exposure group to 2:1 
or 1:2, there was still at least 80% power to detect a hazard ratio of 1.35. If the reference hazard 
were 2 per 100 person years, which is likely for men, there would 70% power to detect a hazard 
ratio 1.30 and 82% power to detect a hazard ratio of 1.35. This suggests that if findings in this 
study had been comparable to what has been seen in other studies, small significant differences 
would be detectable.  
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Aim 3 
In Aim 3 I developed a framework to formally characterize nine possible combinations of 
awareness of HIV status within HIV-discordant couples. This aim was designed to be descriptive, 
rather than analytic. I describe the framework, as well as its implications for interpreting existing 
research and potential uses for framing future research. A brief synopsis of the framework is 
described below 
In HIV-discordant dyads, when both the HIV-infected member and the HIV-uninfected 
members have tested and disclosed, mutual awareness of HIV status ensues. Mutual awareness 
within HIV-discordant couples is one possible “awareness pattern.” In addition, based on various 
combinations of awareness of one’s own HIV status and one’s partner’s HIV status, there are 
eight other patterns. These nine patterns are outlined in Table 3.2. In one extreme scenario (1), 
neither the HIV-positive nor the HIV-negative partners know even their own HIV status. In the 
other extreme scenario (9) both partners know their own HIV status and both have disclosed it to 
the other. The other scenarios (2 through 8) reflect intermediate combinations of awareness. This 
same table can be replicated for couples with concordant HIV-positive or concordant HIV-
negative statuses. However, I focus on HIV-discordant dyads (however stable) because this is the 
setting where there is risk for HIV transmission.  
This framework has implications for understanding prevention research, including the 
results of HIV-discordant couple trials. Most trials, for ethical reasons, recruit couples who are all 
in pattern 9 [2, 45]. If this is the most protective scenario, results may be less generalizable to 
couples in the other eight scenarios. When results are implemented in couples in the other 
scenarios, results may change. 
Understanding risk within each awareness pattern is important, and there are ways to 
study this. There are several large, longitudinal household-based surveys throughout sub-Saharan 
Africa that may be able to address this question observationally [46]. To do this would require 
first determining which couples were HIV-discordant. This could be done through ascertainment 
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of individual HIV status combined with household based information linking couples together 
[47].  Next, it would be necessary to determine what proportion of these couples were in each 
awareness pattern 1through 9. This would require capturing information on each individual’s 
HCT care-seeking and partner-disclosure behaviors. Finally, these couples would need to be 
followed over time for intermediate outcomes (sexual behavior) and ultimate outcomes (HIV 
sero-conversion).  
 Understanding how the prevalence and protectiveness each of these patterns is is 
important for a more nuanced understanding of HIV prevention. It is also important for 
determining how best to optimize HIV prevention. The framework , along with its implications, 
are described in more detail in Chapter 6.   
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Tables and Figures 
 
Table 3.1: Timing of Exposure and Outcome Assessment in ACDIS 
Question Response 
Options 
2004 2005 2006 2007 2008 2009 2010 2011 
a) Do you know 
your status from 
previous HIV 
testing? 
Yes/No/ 
Refused 
  X X 
 
X X 
 
X 
 
X 
b) Provided 
blood for sero-
testing 
 X X X X X X X X 
Caption: Figure 3.1 shows the time points when the exposure and outcome were ascertained. 
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Table 3.2: The Awareness Framework 
 
 
 
HIV- partner 
HIV+ partner 
Not aware of own 
status 
Aware of own 
status, 
has not disclosed 
Aware of own 
status, 
has disclosed 
Not aware of own 
status 
1 
 
2 3 
Aware of own 
status, 
has not disclosed 
4 5 6 
Aware of own 
status, 
has disclosed 
7 8 9 
Caption: Table 3.2 is a preliminary depiction of the Awareness Framework. The Awareness 
Framework is described in more detail in Chapter 6. 
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Figure 3.1 Schematic for Aim 1 
 
Periods of sexual behavior self-report
Longitudinal 
Previous aware 30 days -10 years
Recent aware 1-30 days
Period of sexual behavior self-report
Cross Sectional
Previous aware 30 days -10 years
Recent aware 21-30 days
More Recent 11-20 days
Most Recent 1-10 days
-10 years -1 month Baseline 1 month visit 11 month visit 12 month visit
Figure Legend: This figure shows the exposure groups and one-month periods when outcomes are assessed in the 
longitudinal and cross sectional analyses. In the longitudinal analysis, the cut-point for recent diagnosis is <30 days. At 
baseline, those in the recent group are aware of their HIV status for only part of the month before baseline, whereas those 
in the "previous" group are aware of their HIV status for the entire month preceding baseline. By the one and twelve month 
visits, persons in both groups know their HIV status for the entire month preceding the visit.  In the cross sectional analysis, 
the recent period is divided into three categories: aware for 1-10 days, 11-20 days, or 21-30 days before baseline. In this 
analysis, persons in each of these three exposure categories are compared to those in the previously aware category to see if 
there is a monotonic relationship between how much of the month someone was aware of their status and unprotected sex. 
Caption: Figure 3.1 shows the exposure groups and one-month periods when outcomes were 
assessed in the longitudinal and cross-sectional analyses. In the cross sectional analysis, the recently 
aware period is divided into three exposure categories to see if there is a monotonic relationship 
between how long someone was aware of their HIV status and unprotected sex. In the longitudinal 
analysis, the cut-point for recent diagnosis is <30 days. At basleine those in the “recent” group were 
aaware of their HIVstatus for only part of the month before baseline, whereas those in the “previous” 
group were aware of their HIV status for the entire month prec ding b seline. By the one and tw lve 
month visits, persons in all groups were aware of their HIV status for the entire month preceding the 
visit.  
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Figure 3.2 Examination of a Small Risk Set Using Four Different Time Scales 
 
 
  
Participant 1st visit Censored Tested Birth Year Debut PYs. ~exp. PYs exp. Event 
1 2006 2010 - 1990 2006 0 4 -
2 2006 - 2008 1986 2000 2 1 2009
3 2006 2010 2009 1989 2007 0 2 -
4 2008 - 2008 1986 1999 0 2 2010
5 2006 2009 2006 1989 2003 0 3 -
Time Scale A: Years on Study
1
2
3
4
5
2006 2007 2008 2009 2010
Years on Study
Time Scale B: Time Since Testing
1
2
3
4
5
0 1 2 3 4
Time Since Testing
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Caption: Figure 3.2 displays the same five hypothetical participants on four different time scales. 
Solid lines represent person-time when participants had not received HCT. Dotted lines represent 
person-time after participants had received HCT. Circles represent HIV sero-conversion events. 
On all four time scales, the participants contribute the same number of person-years to each 
exposure category.  They also experience the same number of events. However, when an event 
occurs the participants in the risk set differ. In Aim 2, the primary time scale is time since HIV 
testing. Of note, persons who experience an event after testing for HIV are compared to 
themselves before receiving HCT. They are in their own risk set. Other relevant time scales were 
adjusted for through the use of covariates. In addition, the hazard of HIV acquisition was 
explored on the timeon study time scale. 
 
 
 
 
 
 
 
 
 
Time Scale C: Age
1
2
3
4
5
15 16 17 18 19 20 21 22 23 24 25
Age
Time Scale D: Years Since Debut
1
2
3
4
5
0 1 2 3 4 5 6 7 8 9 10
Years Since Debut
54 
 
54 
 
Figure 3.3: Causal Structure of Selection Bias 
 
 
 
Caption: Figure 3.3 is a causal diagram depicting the simple structure for selection bias as it 
relates to the Aim 2 analysis.  
 
 
 
 
 
 
  
Exposure (HTC) Outcome  
(HIV Acquisition) 
Participation in ACDIS 
Sero-survey 
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Figure 3.4: A Causal Structure of Time Varying Confounding 
 
 
 
 
 
Caption: Figure 3.4 is a causal diagram simplifying the causal structure of time-varying 
confounding affected by a prior exposure. This is one structure that lends itself to the use of 
marginal structural models for valid estimation of the total effect.  
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Figure 3.5: Power Calculation for Aim 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Caption: Figure 3.5 depicted the expected amount of power available to detect hazard ratios form 
1 to 1.5 assuming reference hazard levels of 2, 2.5, and 3 sero-conversions per 100 person years. 
If the reference hazard were 3 per 100 person years (which was expected for women) there was 
83% power to detect a hazard ratio of 1.30 and 92% power to detect a hazard ratio of 1.35. 
Holding the number of people constant, but varying the amount of person-time in each exposure 
group to 2:1 or 1:2, there was still at least 80% power to detect a hazard ratio of 1.35. If the 
reference hazard were 2 per 100 person years (which was expetected for men) there was 70% 
power to detect a hazard ratio 1.30 and 82% power to detect a hazard ratio of 1.35. This suggests 
that if findings in this study were comparable to what was seen in other studies, small significant 
differences would be detectable. 
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CHAPTER IV: Aim 1 
Couples HIV Testing and Counseling Leads to Immediate, Sustained  
Consistent Condom Use among South African Stable HIV-discordant Couples 
Introduction  
 Within stable HIV-discordant couples, HIV-uninfected partners are at ongoing risk for 
HIV acquisition [1]. In sub-Saharan Africa, stable HIV-discordant couples account for as few as 
14% to as many as 94% of new infections [2-3]. Even if the fraction of new infections is on the 
lower end of the range, the absolute number of persons acquiring HIV from stable HIV-infected 
partners is substantial, given 1.8 million annual infections in sub-Saharan Africa [4]. 
 Within HIV-discordant couples, antiretroviral therapy taken by HIV-infected partners or 
pre-exposure prophylaxis taken by HIV-uninfected partners can reduce HIV incidence [5-7]. 
However, not all HIV-discordant couples are eligible for biomedical interventions, and in the 
short-term, these interventions may not reach most HIV-discordant couples.  
 Behavioral interventions, such as couples HIV counseling and testing (HCT) remain 
viable approaches to prevention within HIV-discordant couples. Couples HCT is associated with 
increased condom uptake [8-12]. However, timing of condom uptake is not well understood, nor 
is whether those who continue engaging in unprotected sex engage in fewer unprotected acts. 
 The objective of this analysis is to assess whether HIV-infected persons in stable HIV-
discordant couples increase condom uptake immediately after HCT and whether this behavior is 
maintained. We also assess the impact of HCT on number of sexual acts among persons who 
continue to engage in unprotected sex. To assess these questions we use behavioral data from 
South African HIV-discordant couples enrolled in Partners in Prevention HSV/HIV Transmission 
Study [13].  
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Methods  
Participants 
 Partners in Prevention HSV/HIV Transmission Study was a randomized placebo 
controlled trial to assess the impact of acyclovir taken twice daily by HIV-1/HSV-2 coinfected 
persons on HIV-1 disease progression [14] and HIV-1 transmission to HIV-1 uninfected sex 
partners [13]. Couples were followed for up to 24 months from 2004-2008 or until death, drop-
out, or site closure. This analysis uses data from 508 HIV-infected participants enrolled in the 
South African sites: Gugulethu, Orange Farm, and Soweto. Three HIV-infected participants 
enrolled with two HIV-uninfected partners, but for this analysis, only sexual behavior of the first 
HIV-uninfected partner is analyzed.  
 Couples were screened to identify which were HIV-discordant and eligible. HIV-infected 
participants were eligible if they had CD4 >250, no AIDS-defining illness, and were HSV-2 
seropositive. Couples who did not expect to remain together >24 months and those with no sexual 
activity for >3 months were excluded. Detailed descriptions of recruitment, eligibility, and 
baseline characteristics are available [13-16].   
 
Ethical Approval 
 The trial was approved by the Human Subjects Review Committee at University of 
Washington, and ethical review committees at participating sites. This analysis was approved by 
the Public Health-Nursing Institutional Review Board at University of North Carolina, Chapel 
Hill.  
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Behavioral Interventions 
 Many HIV-infected participants, especially in Soweto, had initially been tested through 
individual provider- or client-initiated HCT months or years before study entry. These 
participants also received couples HCT shortly before study entry. Other HIV-infected 
participants had learned their HIV status for the first time within days or weeks of study entry 
through couples HCT. Thus, by baseline all HIV-discordant couples had participated in couples 
HCT. Couples HCT emphasized the risk for HIV transmission within the couple, as well as risk 
reduction through abstinence or consistent condom use. Additionally, HIV-infected participants 
were counseled and provided with free condoms monthly. HIV-uninfected participants also 
received HCT quarterly, typically with the HIV-infected partner.  
 
Data collection 
Trained research staff collected demographic and sexual behavior information at baseline 
and monthly follow-up using interviewer-administered questionnaires.  
 
Factor of Interest and Outcome Assessment  
The primary factor of interest was timing of HCT for the HIV-infected participant. At 
baseline, HIV-infected participants reported the date of their first HIV-positive test. This date was 
subtracted from the baseline date to determine the number of days since HCT. Some HIV-
infected participants had been tested >30 days before baseline (previously tested). Others learned 
their HIV status <30 days before baseline (newly tested). For some analyses, the newly tested 
group was further divided into three categories: HCT <7, 8-14, and 15-30 days before baseline. 
We explored cut-points within the previously tested category, but did not observe improved 
model fit when a term for HCT >60 days (p=0.7) or >365 days (p=0.3) was included.  
The primary outcome was unprotected sex self-reported by the HIV-infected participant. 
At baseline and each month thereafter, HIV-infected participants were first asked the total 
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number of vaginal and anal sex acts they had with their study partner in the last month and, of 
those acts, the number of times a condom was used. From these responses, numbers of sex acts 
and unprotected sex acts in the last month were calculated.  
At baseline, for previously tested persons (>30 days), all unprotected sex acts must have 
occurred after HCT. For newly tested participants, unprotected sex could have occurred before 
becoming aware of their HIV status or soon after. Persons tested <7 days before baseline were 
unaware of their HIV status for most of the month preceding baseline and serve as a proxy for 
persons unaware of their HIV-positive status. At all subsequent visits, all HIV-infected 
participants were aware of being HIV-infected and in HIV-discordant relationships for the full 
month preceding the visit (Figure 4.1). 
We compared the sexual behavior of newly and previously tested persons at baseline and 
months one, six and twelve. We hypothesized that at baseline the persons tested <7 days before 
baseline would have the highest prevalence of unprotected sex and the highest number of 
unprotected acts, but by month one all groups would be comparable.  
 
Covariates  
A directed acyclic graph was used to identify possible confounders of the association 
between time since HCT and unprotected sex [17]. Individual-level variables were gender, age, 
education, having a living child, having >1 sex partner in the previous month (including >1 study 
partner), and study site. Couple-level variables were marital and cohabitation status, relationship 
length, relationship violence in the past 3 months, and male-female age difference.  
 
Baseline Analyses 
Number of unprotected sex acts is a count. At baseline, we explored the relationship 
between time since HCT and number of unprotected sex acts in several types of models for count 
data: Poisson, negative binomial (NB), zero-inflated Poisson (ZIP), and zero-inflated negative 
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binomial (ZINB). A likelihood ratio test was conducted to determine whether data were over-
dispersed, a scenario when an NB model is a better fit for the data than a Poisson model. A 
Vuong test was conducted to determine whether a zero-inflated model was a better fit for the data 
than a simple NB or Poisson model [18]. These tests indicated that the ZINB model provided the 
best model fit.  
By solving two simultaneous equations, ZINB models generate two sets of parameters 
[18]. The first set, generated using a logistic regression procedure, estimates the odds of being in 
a group that can only get a zero count (i.e. zero unprotected sex acts in the last month) between 
two exposure groups. The second set, generated using a Poisson or NB procedure, models the 
relative number of unprotected sex acts between the exposed and unexposed, conditional on not 
being in the first group. To mitigate influence of extreme observations and facilitate model 
convergence, participants with >15 sex acts (N=20, median number of acts=25) were re-coded 
with 16 sex acts. 
We implemented unadjusted and adjusted analyses. To determine which variables to 
include in the final adjusted analysis, we first ran a model with all covariates presented in Table 
4.1 and interaction terms for age, gender, and site. Interaction terms were retained if they reached 
statistical significance at alpha=0.1. Covariates were removed one-by-one, and retained if 
removal resulted in >10% change in either of the parameter estimates comparing <7 days to >30 
days [19-20]. A fully adjusted model was implemented as a sensitivity analysis.  
 
Longitudinal Analyses 
We used generalized estimating equations (GEE) to assess the effect of HCT timing on 
sexual behavior at baseline, and months one, six, and twelve among couples that remained HIV-
discordant. The month one time point was selected to assess whether behavior change occurred 
soon after HCT and the month six and twelve time points were selected to assess whether 
behavior change was maintained. Logistic models were used in the entire population and NB 
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models were restricted to persons reporting >1 unprotected sex act in a given period. In both 
logistic and NB models, to account for within subject correlation, robust variance estimators with 
exchangeable correlation matrices were used [21]. We calculated odds ratios (OR), relative 
numbers of unprotected acts, predicted probabilities of unprotected sex, predicted numbers of 
unprotected sex acts, and 95% confidence intervals (CI) in each group. We used the same model-
building strategy described above to arrive at final models. Fully adjusted models were 
implemented as sensitivity analyses.  
Both baseline and longitudinal models were restricted to persons sexually active with 
their study partners. Analyses were conducted in SAS v.9.2. (SAS Institute, Cary, North 
Carolina). 
 
Results  
Descriptive Statistics 
Soweto was the most common enrollment site (47%), followed by Gugulethu (39%), and 
Orange Farm (14%) (Table 4.1a). Most HIV-infected participants (77%) were female. The mean 
age of HIV-infected participants was 33 years and 29% had completed secondary school. Most 
HIV-infected participants (82%) had at least one child and few (4%) reported >1 sex partner in 
the last month. Two thirds of couples were married or cohabitating; 79% had been together for >1 
year (Table 4.1b). On average, males were 4.1 years older than females, regardless of which 
partner was HIV-infected. Few HIV-infected participants (4%) reported recent relationship 
violence.  
At baseline, 13% of HIV-infected participants were tested <7 days before baseline, 26% 
8-14 days before baseline, 11% 15-30 days before baseline, and 50% >30 days before baseline 
(Table 4.1a). The median time since HCT was 29 days (IQR: 11 days, 9.2 months) overall and 9.2 
months (IQR: 3.8 months, 25.6 months) among the previously tested.  
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At baseline, almost all HIV-infected participants reported >1 sex act in the last month 
with their study partner (new: 94.1%, previous: 96.1%, p=0.3) (Table 4.2). Among those newly 
tested, 53% reported >1 unprotected sex act in the last month compared to 25% of those 
previously tested (OR: 3.3, CI: 2.3, 4.8). Of those reporting any unprotected sex, the mean 
numbers of unprotected acts were eight (newly tested) and six (previously tested).  
One month after baseline, most HIV-infected participants reported sexual activity with 
study partners (new: 87.9%, previous: 89.1%, p=0.7). Nine percent of those newly tested and 
13% of those previously tested reported any unprotected sex in the last month (OR: 0.7, CI: 0.4, 
1.3). Of those reporting any unprotected sex, the mean numbers of unprotected acts were eight 
(newly tested) and seven (previously tested).  
Twelve months after baseline, most HIV-infected participants continued to report sexual 
activity with study partners (new: 73.6%, previous: 78.2%, p=0.3). Six percent of those newly 
tested and 14% of those previously tested reported any unprotected sex in the last month (OR: 
0.4, 95% CI: 0.2, 0.8). The mean number of unprotected sex acts was 6 in both groups.  
 
Baseline Analyses 
In bivariable analysis, both the zero-inflated odds of unprotected sex and the number of 
unprotected sex acts in the month prior to enrolment were higher among those tested <7 days 
before baseline compared to those tested >30 days before baseline [OR: 9.0 (CI: 3.4, 23.9); 
relative number: 1.7 (CI: 1.2, 2.6)]. The odds of engaging in unprotected sex were also higher 
among those tested 8-14 days and 15-30 days before baseline compared to those tested >30 days 
before baseline, with an apparent dose-response relationship. Number of unprotected acts was 
also higher in these groups, compared to those tested >30 days before baseline (Table 4.3).  
In multivariable analysis with adjustment for study site and marital status, the odds of 
being in a group engaging in unprotected sex were higher among those tested <7 days before 
baseline compared to those tested >30 days before baseline [aOR: 9.3 (CI: 3.6, 24.2)]. Similarly, 
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the number of unprotected sex acts was higher among those tested <7 days before baseline 
compared to those tested >30 days before baseline [adjusted relative number: 1.7 (CI: 1.2, 2.6)]. 
The final adjusted model differed minimally from the fully adjusted model (2%, logistic 
parameter estimate; 8%, NB parameter estimate). Both the adjusted odds and adjusted relative 
number of unprotected sex acts were higher among those tested 7-14 and 15-30 days before 
baseline compared to those tested >30 days before baseline (Table 4.3). 
 
Longitudinal Analyses 
At baseline, the odds of unprotected sex in the last month were substantially higher 
among those tested <7 days before baseline than those tested >30 days before baseline [OR 7.01 
(CI: 3.80, 12.94)], but these groups were similar by month one [OR 0.53 (CI: 0.18, 1.58)] and 
remained similar at months six [OR 0.45 (CI: 0.15, 1.34)] and twelve [OR 0.40, CI (0.10, 1.53)].  
Within each group, the odds of any unprotected sex were lower at month one than at 
baseline [<7 days OR 0.03 (CI: 0.01, 0.11), 8-14 days OR 0.09 (CI: 0.04, 0.19), 15-30 days OR 
0.19 (CI: 0.08, 0.46), >30 days OR 0.45 (CI: 0.32, 0.64)]. Similarly, in all groups, the odds of 
unprotected sex were lower at months six and twelve compared to baseline [Month 6 versus 
baseline: <7 days OR 0.04 (CI: 0.02, 0.13), 8-14 days OR 0.17 (CI: 0.10, 0.31), 15-30 days OR 
0.16 (CI: 0.06, 0.46), >30 days OR 0.69 (CI: 0.48, 1.00)] [Month 12 versus baseline: <7 days OR 
0.04 (CI: 0.01, 0.14), 8-14 days OR 0.10 (CI: 0.05, 0.23), 15-30 days OR 0.06 (CI: 0.01, 0.32), 
>30 days OR 0.66 (CI: 0.47, 0.94)] (Figure 4.2a.) Model-building resulted in no adjustment 
variables, so results are not presented. Full adjustment resulted in a 7% change on the primary 
comparison of interest (month one versus baseline among persons tested <7 days before 
baseline). 
In longitudinal NB analysis, all newly tested participants (<30 days) were analyzed 
together due to sparse data. The number of unprotected sex acts was higher among the newly 
tested than the previously tested at baseline [1.4 (CI: 1.1, 1.8)] but the groups were the same by 
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month one [relative number: 1.0 (CI: 0.6, 1.8)] and remained so at month six [relative number 0.9 
(CI: 05, 1.7)] and twelve [relative number: 1.1 (CI: 0.6, 2.0)].  
Among the newly tested, the number of unprotected sex acts in the last month was similar 
at months one [0.8 (CI: 0.5, 1.3)], six [0.7 (CI: 0.4, 1.1)], and twelve [1.0 (CI: 0.6, 1.7)] compared 
to baseline, but results were imprecise. Among previously tested persons, the number of 
unprotected sex acts was the same at months one [1.1 (CI: 0.9, 1.5)], six [1.0 (CI: 0.7, 1.5)], and 
twelve [1.2 (CI: 0.9, 1.7)] compared to baseline, though also imprecise (Figure 4.2b). Model-
building resulted in no adjustment variables, so results are not presented. Full adjustment resulted 
in a 6% change in the primary comparison of interest (month one versus baseline among newly 
tested persons). 
   
Discussion  
The proportion of HIV-infected persons engaging in unprotected sex with their study 
partners declined considerably in the month after couples HCT, suggesting couples HCT 
facilitated rapid behavior change in these stable HIV-discordant couples. At baseline HIV-
infected persons with previous HCT reported much lower levels of unprotected sex in the last 
month (26%) than persons who had received HCT <7 days before (71%). By month one, once 
both groups had received couples HCT, both reported lower, comparable levels of unprotected 
sex (>30 days: 14%, <7 days: 8%). These levels persisted for one year (>30 days: 19%, < 7 days: 
8%).  
The protective nature of couples HCT for HIV-discordant couples is consistent with 
findings from earlier work in Africa. Couples HCT is associated with high condom uptake among 
HIV-infected persons [22-23], particularly persons in HIV-discordant relationships [8-12]. Our 
analysis is one of the first to show that condom uptake occurs within the first week after couples 
HCT [9].  
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A modest decline in unprotected sex was observed from baseline to month one among 
HIV-infected persons who had received HCT previously. Although these persons had sought 
HCT before, some may not have disclosed their HIV status to sex partners, learned their partner’s 
HIV status, or received counseling with their partners until just before baseline. This decline 
suggests mutual awareness of HIV-discordance is more protective than individual awareness of 
HIV infection. This interpretation is complemented by findings from the full trial: HIV-
uninfected participants reported less frequent unprotected sex with study partners, whose HIV 
status was known, than with outside partners, whose HIV status was often unknown [24].  
After baseline, all HIV-infected persons received individual counseling monthly, partners 
received individual or couples HCT quarterly, and condoms were provided. These factors may 
have contributed to ongoing consistent condom use, though it cannot be determined how 
influential these factors were compared to the initial impact of couples HCT. 
In spite of couples HCT and ongoing counseling, some HIV-infected persons continued 
engaging in unprotected sex with study partners, without reducing the number of unprotected 
acts. Understanding the reasons for ongoing risk and the acceptability of other prevention 
strategies, including biomedical strategies, is essential. 
Understanding the impact of HCT on HIV prevention is critical given its rapid scale-up. 
However, HCT is difficult to assess in randomized settings because withholding HCT is unethical 
and observational studies are typically subject to confounding. This trial provided an opportunity 
to address the impact of couples HCT on HIV prevention in an ethical, rigorous way. We believe 
our results are unlikely to be heavily biased by unmeasured confounding because the main 
difference between exposure groups was the timing of HCT and study enrollment. This typically 
differed by only a few months and a priori seems unlikely to be strongly influenced by social or 
biomedical factors. The similar distribution of observed covariates between exposure groups 
(Table 4.1) and the need for minimal adjustment support this contention.  
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In our study, we knew the precise timing of when someone learned their HIV status, but 
could only determine when sexual behavior occurred within a one-month interval. The 
discrepancy in the timing of these measures leaves ambiguity regarding the temporal order of 
HCT and sexual behavior for newly tested persons. For example, someone tested 10 days prior to 
baseline spent the first 20 days of the month unaware of their HIV status and the final 10 days 
aware. If they reported unprotected sex during this thirty-day period, it could have occurred 
before, after, or both before and after HCT. Two features of our study design lend evidence to the 
strong possibility that unprotected sex occurred predominantly before HCT. First, once newly 
tested persons had been aware of their HIV status for at least one month they reported lower 
levels of unprotected sex. Second, at baseline, the relationship between the amount of time 
someone was unaware of their HIV status and the odds of unprotected sex was monotonic. The 
more time someone spent unaware of their HIV status, the more likely they were to report any 
unprotected sex at baseline. If this trend were to continue, a group unaware for the entire month 
would be expected to experience an even higher probability of unprotected sex relative to the 
previously tested.  
This analysis relied on self-report which is subject to social desirability. If persons were 
more likely to over-report condom use after HCT than before, effect measures would be 
exaggerated. Biomarkers suggest that these differences are unlikely to be explained entirely by 
this concern. In the full trial population, although consistent condom use was likely over-reported, 
it was strongly associated with reductions in HIV acquisition [25].  
Caution is needed when generalizing results beyond these stable HIV-discordant couples. 
Persons enrolling in HIV prevention trials may be more motivated to adopt HIV prevention 
behaviors than the general population. Additionally, persons who are willing to enroll with 
partners may differ from persons who are unwilling. Most couples were in long-term marital or 
cohabiting relationships and levels of intimate partner violence were low [26]. Couples HCT may 
not be as protective in segments of the population in less stable, more violent partnerships[27]. 
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Understanding effectiveness of couples HCT in these less stable partnerships is an area for future 
investigation.  
Our findings raise questions about the current HCT paradigm, which is not typically 
couple-oriented. When stable couples learn that they are in HIV-discordant relationships they 
adopt consistent condom use quickly, but such marked behavior change is not typically reported 
after individual HCT [28-29]. Couples HCT assures simultaneous disclosure, has a substantial 
impact on sexual behavior [29] and may have an impact on adherence to biomedical prevention 
[7, 30]. However, most current HCT efforts are aimed at individuals, not couples, leading to 
missed HIV prevention opportunities. Strategies, such as home-based testing [31], supportive 
HIV-disclosure counseling [32], voucher-based recruitment [33], and provider-assisted partner 
notification [34] can be used to inform persons of HIV-discordance. These strategies, which are 
feasible, acceptable, effective, and cost-effective, must be public health priorities.  
In summary, our results add to a growing body of evidence demonstrating that couples 
HCT is effective at rapidly increasing condom-uptake, facilitating ongoing condom use, and 
possibly lowering rates of HIV acquisition [10-11, 25]. Although initial findings were published 
nearly two decades ago, most countries have been slow to implement couple-based strategies. 
With expanding HCT capacity in Africa [35], decision-makers now need to consider how to reach 
couples. Such expansion will help a high risk group make informed sexual health decisions and 
likely prevent a substantial number of infections.  
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Tables and Figures 
 
Table 4.1a Baseline characteristics of HIV-infected participants by time since HCT 
Characteristics 
Newly Tested Previously Tested 
<7 days 8-14 days 15-30 days >30 days 
N=65 (13%) N=134 (26%) N=55 (11%) N=254 (50%) 
Gender 
        
 
     Male 14 (21.5) 31 (23.1) 16 (29.1) 58 (22.8) 
 
     Female 51 (78.5) 103 (76.9) 39 (70.9) 196 (77.2) 
Age* 
        
 
      <25 12 (18.8) 18 (13.6) 4 (7.3) 48 (18.9) 
 
      25-34 27 (42.2) 53 (40.2) 35 (63.6) 132 (52.0) 
 
      >35 25 (39.1) 61 (46.2) 16 (29.1) 74 (29.1) 
Education 
        
 
     <secondary 44 (67.7) 111 (82.8) 37 (67.3) 167 (67.7) 
 
     >secondary 21 (32.3) 23 (17.2) 18 (32.7) 87 (32.3) 
Has a living child 
      
 
      Yes 55 (84.6) 100 (74.6) 44 (80.0) 218 (85.8) 
 
      No 10 (15.4) 34 (25.4) 11 (20.0) 36 (14.2) 
>1 sex partner  
        
 
       Yes 4 (6.2) 6 ( 4.5) 1 (1.8) 7 (2.8) 
 
       No 61 (93.8) 128 (95.5) 54 (98.2) 247 (97.2) 
Study Site 
        
 
      Gugu-  
      lethu 
24 (36.9) 79 (59.0) 30 (54.5) 62 (24.4) 
 
      Orange    
      Farm 
13 (20.0) 22 (16.4) 10 (18.2) 28 (11.0) 
        Soweto 28 (43.1) 33 (24.6) 15 (27.3) 164 (64.6) 
*Results may not add to column totals due to missing data. 
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Table 4.1b Baseline characteristics of HIV-infected couples by time since HCT 
Couple Characteristics 
Newly Tested 
Previously 
Tested 
<7 days 8-14 days 15-30 days >30 days 
N=65 (13%) N=134 (26%) N=55 (11%) N=254 (50%) 
Marital/Cohabitation Status 
      
 
Not married, not                  
cohabitating 
16 (24.6) 48 (35.8) 26 (47.3) 81 (31.9) 
 
Not married,  
cohabitating 
40 (61.5) 70 (52.2) 23 (41.8) 120 (47.2) 
 
Married 9 (13.9) 16 (11.9) 6 (10.9) 53 (20.9) 
Relationship length* 
        
 
<1 year 15 (23.1) 40 (30.1) 14 (25.5) 38 (15.1) 
 
1-3 years 14 (21.5) 46 (34.6) 17 (30.9) 90 (35.9) 
 
>3 years 36 (55.4) 47 (35.3) 24 (43.6) 123 (49.0) 
Age Difference*† 
        
 
<5 years 35 (55.6) 70 (53.0) 32 (59.3) 134 (53.2) 
 
>5 years 28 (44.4) 62 (47.0) 22 (40.7) 118 (46.8) 
Partner Violence <3 Months 
       
 
Yes 3 (4.6) 5 ( 3.7) 1 ( 1.8) 11 (4.3) 
 
No 62 (95.4) 129 (96.3) 54 (98.2) 243 (95.7) 
*Results may not add to column totals due to missing data. 
†Male age minus female age regardless of which partner is HIV-infected 
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Table 4.2 Sexual Behavior in the Previous Month Comparing Newly to Previously Tested at Baseline, 
Month One, and Month Twelve  
 
Baseline (N=508) 1-Month (N=487) 12-Month (N=376) 
Timing of testing New Previous New Previous New Previous 
Entire Population 
n=254 
(50%) 
n=254 
(50%) 
 n=239        
(49%) 
n=248 
(51%) 
n=174 
(46%) 
n=202  
(54%) 
Total sex acts       
     N (%) ≥1 239 (94.1) 244  (96.1) 210  (87.9) 221  (89.1) 128 (73.6) 158  (78.2) 
     N (%) = 0 15     (5.9) 10      (3.9) 29    (12.1) 27    (10.9) 46   (26.4) 44    (21.8) 
     Mean (SD) 7.1  (10.3) 6.9     (9.3) 5.3     (6.5) 6.3     (7.7) 4.4    (5.3) 4.9     (5.6) 
     Median (IQR) 4       (3,8) 4        (3,8) 3       (2, 5) 4       (2, 8) 3      (0, 7) 3       (1, 7) 
 Unprotected sex acts 
      
 
    N (%) ≥1 134 (52.8) 64    (25.2) 22      (9.2) 31    (12.5) 11     (6.3) 29    (14.4) 
     N (%) = 0 120 (47.2) 190  (74.8) 217  (90.8) 217  (87.5) 163 (93.7) 173  (85.6) 
     Mean (SD)  4.1    (9.7) 1.5     (5.1) 0.7     (3.8) 0.9     (4.4) 0.4    (2.1) 0.8     (3.2) 
     Median (IQR) 1      (0, 4) 0       (0, 1) 0       (0, 0) 0       (0, 0) 0       (0, 0) 0       (0, 0) 
Persons with >1 
unprotected act 
n=134 
(68%) 
n=64    
(32%) 
n=22 
(42%) 
n=31                    
(58%) 
n=11  
(28%) 
n=29                                                                                      
(73%) 
Total sex acts  
     Mean (SD) 9.4   (12.2) 7.5      (9.6) 13.1 (12.9) 10.2 (10.4) 9.0 (5.1) 7.8 (6.0) 
     Median (IQR) 5     (3, 12) 4.5   (2.5, 9)   7   (4, 20) 8      (4, 12) 8  4, 12) 7   (4, 9) 
Unprotected sex acts       
    Mean (SD)  7.8   (12.2) 5.8     (9.0) 7.7   (10.5) 7.1  (10.8) 6.1 (6.4) 5.7 (6.6) 
   Median (IQR) 4       (2, 9) 3        (1, 6) 2.5    (1, 8) 4     (2, 8) 2 (1, 12) 3   (2, 6) 
SD=standard deviation, IQR=inter-quartile range 
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Table 4.3 Unadjusted and Adjusted Baseline ZINB Models by Time Since HCT 
  
Unadjusted Models  Adjusted Models* 
  
OR of any   Relative # of OR of any   Relative # of 
  
unprotected sex unprotected acts unprotected sex unprotected acts 
 
 (95% CI) (95% CI) (95% CI) (95% CI) 
Time Since HCT 
        
 
>30 days 1. 
 
1. 
 
1. 
 
1. 
 
 
15-30 days 2.6 (1.2, 5.4) 1.5 (0.9, 2.4) 3.2 ( 1.5,  7.0) 1.7 (1.1, 2.8) 
 
8-14 days 3.5 (1.9, 6.4) 1.1 (0.8, 1.6) 4.2 (2.2, 8.0) 1.2 (0.8, 1.7) 
 
<7 days 9.0 (3.4, 23.9) 1.7 (1.2, 2.6) 9.3 (3.5, 24.2) 1.7 (1.2, 2.6) 
ZINB=zero-inflated negative binomial; HCT=HIV counseling and testing; OR=odds ratio; 
CI=confidence interval 
* Adjusted for marital status and study site 
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Figure 4.1 Schematic of Baseline and Longitudinal Analyses 
  
  
 
Periods of sexual behavior self report used in this analysis 
 
Time Since HCT 
 
>30 days                                       
15-30 days 
 
                  
8-14 days 
  
                
<7 days 
   
              
  
        
    
  
  
Baseline 1 month   6 month   
 
12 month 
Caption: Figure 4.1 displays the four exposure groups and time periods when outcomes are assessed. At 
baseline, those in the newly tested groups (<7 days, 8-14 days, 15-30 days) are aware of their HIV status 
for only part of the month before baseline (indicated in gray), whereas those in the previously tested 
group (>30 days) are aware of their HIV status for the entire month before baseline (indicated in black). 
The more recently someone was tested, the longer they spent unaware of their HIV status. By months 
one, six and twelve, persons in all groups had known their HIV status for >30 days.  
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Figure 4.2a Unadjusted Predicted Probability of Any Unprotected Sex Acts (95% CIs) by 
Time since HCT 
 
Figure 4.2b Unadjusted Predicted Number of Unprotected Sex Acts (95% CIs) by 
Time since HCT 
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Caption: Figure 4.2a depicts the predicted probability of unprotected sex among sexually active 
persons in all four groups over a one-year period. At baseline, the more recently someone had 
learned their HIV status, the higher the probability of unprotected sex. By month one, the 
predicted probability of unprotected sex declined in all four groups and remained lower over 
time. Figure 4.2b depicts the predicted number of unprotected sex acts among persons who 
engaged in unprotected sex at four time points over a one-year period. All newly aware groups 
are collapsed together due to sparse data. At baseline persons who were newly tested reported 
more unprotected sex acts in the last month than persons who were previously tested. One month 
after baseline, the predicted number of unprotected sex acts declined in the newly tested group 
and remained constant (though imprecise) in both groups over time. 
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CHAPTER V: Aim 2 
The Effect of HIV Counseling and Testing on HIV Acquisition among South African Youth:  
Evidence of Protectiveness 
 
Introduction 
Persons aged 15-24 years in sub-Saharan Africa are at high risk for HIV acquisition [1]. 
In South Africa, the country with the world’s largest burden of HIV infection, an estimated 21% 
of girls and 5% of boys acquire HIV by the time they are 24 years old [2-4]. Youth in this age 
range urgently need effective HIV prevention interventions to slow HIV incidence. 
In recent years, HIV counseling and testing (HCT) has been scaled up rapidly in sub-
Saharan Africa [5-6]. From 2005 to 2008, the proportion of South Africans who ever sought HCT 
increased from 31% to 51% [2, 7]. HCT availability continued to increase in healthcare and other 
settings in South Africa in response to a national “know your status campaign,” aimed at testing 
15 million South Africans in a 14-month period from 2010-2011 [8]. South African youth tend to 
report lower uptake of HCT than adults [7, 9-10], in spite of the majority being sexually active by 
their mid-teens [4, 11]. To increase HCT uptake among this age group, introducing HCT into 
secondary schools has been debated [12-13], with the effect of HCT on incidence being one key 
component.  
The impact of HCT on HIV acquisition has not been studied among youth. Studies in 
adults suggest HCT leads to no change or a modestly elevated HIV acquisition rate [14-15], a 
trend that may be due to behavioral disinhibition following testing [16], testers being higher risk 
people, or spurious statistical associations. The impact of HCT on HIV acquisition may be 
different among youth, as they are socially, and behaviorally different from adults [17]. Many 
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youth have not yet experienced sexual debut, and early behavioral interventions, including HCT, 
may be more effective during this formative period [18]. Sexually active youth are also not 
typically in marital or cohabitating unions [19], and condom initiation or continuation may be 
easier to negotiate in these types of relationships. An ongoing community-randomized study, 
Project Accept, is assessing the impact of intensive community-based HCT versus standard 
clinic-based HCT on community incidence among persons 16-32 in several developing countries, 
including South Africa [20]. However, understanding the impact of HCT on HIV acquisition at an 
individual level is necessary as well.  
We conducted a retrospective cohort study using data from a large demographic 
surveillance area in rural South Africa [21] to compare HIV acquisition among youth who 
received HCT to those who did not from 2006-2011.  
 
Methods  
 
Setting  
The study was conducted in Hlabisa, KwaZulu Natal, South Africa, a rural sub-district 
heavily affected by the HIV epidemic. HIV prevalence in this area is estimated at 23%, and HIV 
incidence rate is 3.4 per 100 person-years [22-24]. In 2005, HCT was introduced in all 17 primary 
health centers to support the scale-up of a decentralized HIV care and treatment program [25]. 
From 2005-2010, persons could voluntarily seek counselor-delivered HCT at these centers. 
Additionally, health providers in these centers referred all antenatal, sexually transmitted 
infection, and tuberculosis patients for the same counselor-delivered HCT with high uptake [26]. 
Home- and mobile- HCT were also available in some parts of the sub-district at a lower volume 
beginning in 2008, and these services were also counselor delivered [27]. All HCT services 
incorporate education about how HIV is transmitted, as well as counseling on sexual behavior 
risk reduction. All of these services use rapid tests so clients are provided with results on the day 
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they are tested. This analysis assesses the impact of all of these HCT services on HIV acquisition 
among youth using the data sources described below.  
 
Study Design  
Demographic characteristics were assessed semi-annually in an enumerated part of the 
Hlabisa sub-district through the Africa Centre Demographic Surveillance. Individual-level 
characteristics, such as age, gender, and education, were collected in this survey, as well as 
household-level characteristics, such as distance to the nearest primary health center.  
In this same area, a separate annual population-based HIV Survey was conducted 
including a laboratory assessment of HIV status. For consenting participants, blood was obtained 
via finger prick and prepared into dried blood spots. A serial HIV testing algorithm with two 
ELISAs was used: Vironostika HIV-1/HIV-2 Microelisa System (Biomérieux, Durham, NC, 
USA), followed by Wellcozyme HIV 1+2 GACELISA (Murex Diagnostics, Benelux B.V., 
Breukelen, The Netherlands) [21].  The HIV Survey also assessed whether the participant had 
previously sought HCT [21] and self-reported sexual behavior.  
For this analysis, in each year, one Demographic Surveillance record and one HIV survey 
record were merged together using a unique identifier. These annual records were combined so an 
individual’s HCT history and HIV status could be assessed over time. We conducted a 
retrospective cohort study in this population.  
Of note, the exposure (HCT self report) and the outcome (HIV status) were ascertained 
independently. On the day of the HIV survey participants reported whether or not they had sought 
HCT. They also provided blood for laboratory-based HIV testing. Participants did not learn their 
HIV status on the day of the HIV Survey. Therefore participants who reported being HCT-
exposed learned their HIV status from one of the means described above prior to the survey.  
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Eligibility 
To be eligible for this study, persons had to have at least two reports of HCT between 
2006 and 2010 in the HIV survey, though they could have had up to five reports. At the first 
report, participants had to report not being aware of their HIV status from HCT and at the second 
report participants could either report being aware or not being aware of their HIV status from 
HCT. The midpoint between these two reports was considered.baseline. Those who reported HCT 
at the second report were considered HCT-exposed at baseline and those who reported no HCT at 
the second report were considered HCT-unexposed at baseline. Variables from first time point 
were used for adjustment with the baseline value. Some persons (20%) did not have HCT reports 
from two consecutive years (e.g. 2006 and 2007), so a report from a subsequent year is used as 
the second report (e.g. 2008). All persons in the study had to have at least two valid HIV test 
results from the HIV survey—one negative result before baseline and one negative, positive, or 
indeterminate result after baseline.  The analysis was restricted to persons 15-24 years old at 
baseline. 
 
Ethical Approval 
 Ethics permission for the demographic and HIV surveillance was obtained from the 
University of KwaZulu-Natal research ethics committee. The current analysis was approved by 
the Public Health-Nursing Institutional Review Board at the University of North Carolina, Chapel 
Hill.  
 
Data Collection  
All questions in the Demographic Surveillance were collected by a trained interviewer 
and reported by a household proxy. All questions on the HIV survey, including HCT-exposure 
and the sexual behavior assessment, were administered by a trained interviewer of the same sex 
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as the participant and reported by the participant. Questions were administered in isiZulu, the 
local language. 
 
Exposure Assessment 
HCT exposure is based on self-report collected annually in the HIV survey from 2006-
2010. Specifically participants were asked annually: “Do you know your HIV status from 
previous HIV testing?” Participants who responded “no” to this question at their first visit and 
“yes” to this question at their second visit are considered “HCT-exposed” at baseline. Persons 
who responded “no” to this question at both their first and second visits are considered “HCT-
unexposed” at baseline. Those who responded “yes” to this question at both time points were 
excluded, as we could not estimate when they sought HCT or what their covariate values would 
have been then. All participants who were HCT-exposed at baseline remained HCT-exposed for 
the remainder of follow-up. Some participants who were HCT-unexposed at baseline reported 
subsequent HCT-exposure (e.g., in their fourth survey round). For these participants, HCT was 
treated as a time-varying exposure. The first portion of person-time was characterized as HCT-
exposed and the second portion was characterized as HCT-unexposed.  
 
Outcome Assessment 
The primary outcome in this analysis is HIV acquisition ascertained in the HIV survey. For 
participants who seroconverted, the time of HIV seroconversion was calculated as the midpoint 
between the last HIV-negative result and the first HIV-positive result minus thirty days. Thirty 
days were subtracted to allow for a window period between the time HIV was acquired and the 
time when it could have been detected [28]. For persons who did not acquire HIV during follow-
up, their follow-up time extended from enrollment until their last HIV-negative or indeterminate 
test result minus thirty days. Persons who refused to participate in the sero-survey after their last 
HIV-negative test are characterized as “refusals” at the time of refusal.  
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Statistical Analyses  
A directed acyclic graph was used to identify a minimally sufficient set of covariates to 
include in the analysis [29]. These included gender, age, year of study initiation, distance to the 
nearest study clinic, education, pregnancy status, fatherhood status, whether or not sexual debut 
had occurred, number of sex partners in the last year, and condom use at last sex [23, 30-32]. For 
a fraction of participants, information was missing for education, pregnancy, fatherhood, sexual 
debut, number of partners in the last year, and condom use at last sex. Multiple imputation using 
Markov Chain Monte Carlo simulation was used to impute missing values of these covariates 
separately for the HCT-exposed and HCT-unexposed participants [33]. Five complete imputed 
data sets were generated using PROC MI and results were combined using PROC MIANALYZE 
in SAS 9.2 [34].  
Unadjusted HIV incidence rates were calculated in the two exposure groups and within 
strata of covariates (Table 5.2). Persons who were initially HCT-unexposed and became HCT-
exposed contributed person-time to both exposure groups. We used Cox proportional hazard 
models to compare the association of HCT with time to HIV acquisition. We ran two main 
analyses: unadjustedand inverse probability of exposure and censoring weighted (i.e. a marginal 
structural model) (Table 5.3) [35-36]. Censoring weights were based on refusal. In all models, 
time since HCT was used as the primary analytic time scale [37] and the exposure and covariates 
were treated as time-varying. When time-varying confounders, such as sexual behavior, are 
influenced by a prior exposure, such as HCT, covariate-adjusted models can give biased results 
even in the absence of uncontrolled confounding [35]. In such settings, marginal structural 
models are more appropriate. 
In these marginal structural models, inverse probability of exposure and censoring 
weights were constructed in a population with one observation per person-quarter [35]. Exposure 
weights were estimated as follows: the probability of each person receiving their exposure 
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history, conditional on their time-updated covariate history, was calculated using pooled logistic 
regression. We took the inverse of this probability as the denominator of the weight. The 
numerator of the weight was a similar probability, based only on time-fixed covariates. Together, 
these created a set of stabilized inverse probability of exposure weights. Stabilized inverse 
probability of censoring weights were estimated similarly, except that exposure history was 
entered into the model along with covariates. Exposure and censoring weights were multiplied to 
produce final stabilized weights. Weights were well-behaved with a mean of 1.02 (standard 
deviation=0.34) and a median of 0.98 (range =0.10-7.78). Values were attenuated at the 1
st
 and 
99
th
 percentiles to avoid undue influence of extreme weights [38]. The hazard of HIV acquisition 
by HCT status was assessed in the weighted population using pooled logistic regression models 
to estimate discrete time hazard models with robust variance estimators and independent 
correlation matrices. All statistical analyses were implemented using SAS 9.2 
 
 
Results 
 
Study Population 
Overall, 18,385 persons aged 15-24 years were enumerated in the catchment area in at 
least two surveillance rounds from 2006-2010 (Figure 5.1). Youth who reported knowing their 
HIV status at their first HCT report were excluded (N=3985, 22%), as were persons infected with 
HIV before baseline (N=1054, 6%). Persons with insufficient HCT information, HIV status 
information, or both and were also excluded. Most of these excluded persons were migrants who 
were enumerated but not residing in the catchment area for much of the time period (N=6013, 
33%), and some (N=3372, 18%) were persons who declined participation. The study sample 
included the remaining youth (N=3959, 22%). Of these youth, 1167 (29%) were HCT-exposed 
and 2792 (71%) were HCT-unexposed at baseline. Of the persons who were HCT-unexposed, 
38% became HCT-exposed during their follow-up period (N=1064) and the rest remained 
unexposed during follow-up (N=1728). 
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Population Characteristics 
The study population was 51% male and 49% female with a median age of 17 (inter-
quartile range: 16-20) (Table 5.1). Most women (83%) reported having never been pregnant and 
the most men (95%) reported never having fathered a child. At baseline, two thirds of participants 
reported not having experienced sexual debut (66%) and reported no sexual partners in the last 
year (68%), while 4% reported two or more partners in the last year. Of those who were sexually 
active, 43% reported condom use at last sex. Persons who were HCT-exposed at enrollment were 
more likely to be female, older, and more sexually experienced, with a greater proportion having 
experienced sexual debut, reporting >1 partner in the last year, and having been pregnant.  
 
HIV Incidence and Time to Event Analysis  
In the periods after HCT exposure, participants experienced 117 events over 3834 
person-years of follow-up [incidence rate: 3.05 (95% CI: 2.55, 3.66) per 100 person-years]. In the 
periods of HCT non-exposure, participants experienced 131events over 4702 person-years of 
follow-up [incidence rate: 2.79 (95% CI: 2.35, 3.31) per 100 person-years] (Table 5.2).  
 In unadjusted Cox analysis, comparing HCT-exposed persons to HCT-unexposed 
persons, the hazard of HIV acquisition was 1.00 (95% CI: 0.78, 1.29) (Table 5.3, Figure 5.2). In 
the marginal structural model, the hazard of HIV acquisition was 0.59 (95% CI: 0.45, 0.78) 
(Table 5.3). Most of the change in estimate was attributed to weighting for gender, sexual debut, 
and having ever been pregnant. Results were not statistically different between men (HR: 0.66, 
95% CI: 0.37, 1.38) and women (HR: 0.57, 95% CI: 0.41, 0. 78) or between those who were <20 
years old (HR: 0.59, 95% CI: 0.43, 0.82) and those who were >20 years old (HR: 0.56, 95% CI: 
0.31, 0.97).  
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Sensitivity Analyses 
In a marginal structural model with inverse probability of exposure weights, but no 
censoring  weights, the hazard ratio was essentially identical to the main effect: 0.59 (95% CI: 
0.44, 0.78), suggesting that confounding, not censoring, was driving the difference between the 
unadjusted and weighted effects. In a marginal structural model without imputed covariates, the 
hazard ratio was similar, but estimated less precisely (HR: 0.64, 95% CI: 0.46, 0.89). Hazard 
ratios were similar in the first 1.5 years after HCT (HR: 0.65 (95% CI: 0.40, 1.05) as in the next 
three years after HCT (HR: 0.57, 95% CI: 0.40, 0.79), suggesting durability. In standard 
multivariate analysis adjusting for time-varying confounders, the hazard of HIV acquisition was 
0.64 (95% CI: 0.48, 0.85). 
 
Discussion  
Our observations strongly suggest that youth living in this high prevalence environment 
experienced reduced HIV acquisition after HCT, an effect that was sustained for over four years. 
Youth who had received HCT and those who had not experienced a similar rate of HIV 
acquisition. However, youth who had sought HCT were at higher risk for HIV. They were more 
sexually experienced, making them more behaviorally vulnerable, and more likely to be female, 
making them more biologically vulnerable. Once these risk factors had been accounted for, it 
became clear that HCT had in fact been protective.  
Our findings differ from similar studies conducted among adults, which suggested that 
HCT had no effect, or even a small harmful effect on HIV acquisition [14-15, 40]. Youth may be 
affected by HCT differently than adults. Socially, youth are less likely to be in marital or 
cohabitating unions than adults [19].HCT may be better able to facilitate adoption or continuation 
of condom use in the context of these non-cohabiting, non-marital unions [7]. Similarly, youth 
may be able to select other HIV-uninfected partners, an option that may not be possible in adults 
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in long-term unions. Additionally, youth are still in a formative period, and may be better able to 
adopt behavioral messages than adults who have already formed behavioral habits [18].  
The causal mechanism underlying the relationship between HCT and HIV acquisition is 
not known. Exploratory work suggests that at later time points, youth who sought HCT were 
more likely to report condom use at last sex than youth who had not. Similar relationships were 
not seen for other behavioral factors, such as sexual debut or number of sex partners in the last 
year. HCT referral to medical male circumcision is unlikely to explain the effect, as it was not 
introduced into the catchment area until the very end of the study period at low volumes. Another 
possibility is that after HCT HIV-uninfected youth sought other partners who were also HIV-
uninfected, something that is possible in an era with high HCT uptake.  
Delivering HCT in non-stigmatizing ways is critical, as youth often report judgmental 
care-seeking environments [41]. Models of adolescent-oriented service delivery have been put 
forth, and understanding whether these models improve service uptake or sexual health outcomes 
is important [42]. The majority of youth reported their last HCT encounter was from a primary 
health center, with a substantial fraction reporting home-based or mobile testing. However, this 
question was only available at the end of the study, limiting our ability to assess the impact of 
testing modality.  
Although HCT was protective in this population, youth who received HCT still 
experienced an extremely high HIV incidence rate of 3 per 100 person-years. Using HCT for 
delivery of or linkage to other prevention strategies is therefore essential. HCT may be more 
effective at changing behavior among HIV-uninfected adults in HIV-discordant relationships 
[43], and similar dyad-oriented strategies should be explored in youth in ongoing relationships. 
Additionally HCT must be used for linkage to medical male circumcision among HIV-uninfected 
young men [44] and pre-exposure prophylaxis among HIV-uninfected young men and women, 
when appropriate and available [45]. For HIV-infected persons, HCT has long been a means of 
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linkage to care for individual health, but is becoming even more important as treatment is used 
for prevention of onward transmission [46].  
Large groups of youth were excluded or lost, which raises concerns about selection bias 
and non-generalizability. First, many persons who were HCT-exposed at the time of first report 
were excluded because we could not estimate when HCT exposure had occurred or what 
covariate values would have been at the time of exposure. If the rate of HIV acquisition had been 
higher in this group of testers, HCT would appear more protective than it truly was. Additionally, 
we excluded persons with insufficient HCT information, HIV information, or both.  About two 
thirds (64%) of these persons were non-residents, typically persons residing outside of the 
catchment area for work. In contrast, only 4% of included youth were non-residents at baseline, 
suggesting our findings are best generalized to residents. Of the remaining excluded youth, many 
had sufficient HCT information (N= 1611), but insufficient HIV information. The proportion of 
these excluded youth that was HCT-exposed at baseline (25%) was comparable to the proportion 
of included youth that was HCT-exposed at baseline (29%), and covariate distributions by HCT 
status were similar as well. This suggests that outcome distributions may be comparable, as well, 
but this is not testable. 
This analysis may not have fully accounted for all factors that influence the effect of 
HCT on HIV acquisition. Some sexual behaviors, such as sexual debut, may have been under-
reported due to social desirability, a phenomenon that is likely as many HIV acquisition events 
(77/248) occurred among persons who had not experienced sexual debut. An alternative 
explanation for acquisition among youth who did not report debut is sexual abuse. In South 
Africa, boys 15-26 frequently report perpetrating rape [47] and school-age boys and girls report 
being victims of forced or coerced sex [48]. These factors may not have been captured in 
questions about debut and partnerships, but may have been important risk factors. Additionally, 
behavioral constructs, such as perceived risk, behavioral intentions, awareness of partners’ HIV 
status and disclosure were not captured, and these factors could have affected results [49].  
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Given these potential sources of bias, replication of these results in similar settings is 
warranted. The ongoing study, Project Accept is assessing whether an intensive community-based 
HCT model is more effective at decreasing HIV acquisition than standard-of-care clinic based 
HCT [20]. Results will contribute critical new insights to this question.  
HCT is a necessary first step for reducing HIV transmission through linkage of HIV-
infected persons to treatment. Based on our observations, HCT may be effective at reducing HIV 
acquisition among youth, even in the absence of biomedical strategies. These findings are 
important in light of South Africa’s recent debates about whether to implement HCT in secondary 
schools [13]. Although our analyses do not determine whether overall benefits of HCT outweigh 
the possible psychosocial harms among youth in this setting, HCT is likely beneficial from a 
prevention perspective. Promotion of HCT to South African youth may help slow the rate of HIV 
acquisition in this high risk population.  
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Tables and Figures 
 
Table 5.1 Baseline Characteristics of the Study Population 
  
HCT-unexposed HCT-exposed Total 
    N=2792 N=1167 N=3959 
Gender 
      
 
Female 1247 45% 690 59% 1937 49% 
 
Male 1545 55% 477 41% 2022 51% 
Age 
       
 
15-19 2268 81% 856 73% 3124 79% 
 
20-24 524 19% 311 27% 835 21% 
Year of study entry 
      
 
2006 1887 68% 609 52% 2501 63% 
 
2007 553 20% 220 19% 773 20% 
 
2008 309 11% 273 23% 582 15% 
 
2009 43 2% 65 6% 108 3% 
Distance to Nearest Clinic 
     
 
<2 km 838 30% 410 35% 1248 32% 
 
2-5 km 1398 50% 559 48% 1957 49% 
 
>5km 556 20% 199 17% 755 19% 
Education 
      
 
<primary 657 25% 206 19% 863 23% 
 
some secondary 1801 68% 719 66% 2520 67% 
 
> secondary 188 7% 170 16% 358 10% 
Ever had sex 
      
 
Yes 728 29% 465 47% 1193 34% 
 
No 1749 71% 532 53% 2281 66% 
Condom Use at Last Sex (among sexually active) 
  
 
Yes 305 43% 192 42% 497 43% 
 
No 407 57% 261 58% 668 57% 
Sex Partners in Last 12 months* 
     
 
0 1799 73% 555 56% 2354 68% 
 
1 595 24% 384 39% 979 28% 
 
>2 82 3% 46 5% 128 4% 
Ever Pregnant (females) 
     
 
Yes 159 14% 146 24% 305 17% 
 
No 984 86% 462 76% 1446 83% 
Ever Father (males) 
      
 
Yes 51 4% 34 8% 85 5% 
 
No  1341 96% 381 92% 1722 95% 
        Caption: Table 5.1 compares the baseline factors between the HCT-exposed and HCT-unexposed groups 
observed in this analysis. Covariate totals may not add up to the column total due to missing data.  
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Table 5.2 Incidence of HIV Acquisition by HCT Exposure and Covariates 
Variable  Events PYs IRR (95% CI) 
       
HCT   
  
    
 
Unexposed 131 4702 2.79 (2.35, 3.31) 
 
Exposed  117 3834 3.05 (2.55, 3.66) 
Gender 
   
  
 
Female 190 4344 4.37 (3.79, 5.04) 
 
Male 58 4193 1.38 (1.07, 1.79) 
Age 
   
  
 
15-19 188 6570 2.86 (2.48, 3.30) 
 
20-24 60 1966 3.05 (2.37, 3.39) 
Year of study entry 
   
  
 
2006 187 6120 3.06 (2.65, 3.53) 
 
2007 42 1472 2.85 (2.11, 3.86) 
 
2008 18 848 2.12 (1.34, 3.37) 
 
2009 1 96 1.04 (0.15, 7.36) 
Distance to Nearest Clinic 
   
  
 
<2 km 81 2804 2.89 (2.32, 3.59) 
 
2-5 km 129 4166 3.10 (2.61, 3.68) 
 
>5km 38 1567 2.43 (1.76, 3.33) 
Education 
   
  
 
< primary 41 1724 2.38 (1.75, 3.23) 
 
some secondary 177 5733 3.09 (2.66, 3.58) 
 
> secondary 30 1080 2.78 (1.94, 3.97) 
Ever had sex 
   
  
 
Yes 171 3730 4.58 (3.95, 5.32) 
 
No 77 4806 1.60 (1.28, 2.00) 
Condom use at last sex 
     
 
Yes 56 1397 3.08 (2.65, 5.21) 
 
No 115 2333 4.93 (4.11, 5.92) 
Sex Partners in Last 12 months 
     
 
0 84 4859 1.73 (1.40, 2.14) 
 
1 152 3291 4.62 (3.94, 5.42) 
 
>2 12 387 3.10 (1.76, 5.46) 
Ever Pregnant (females) 
   
  
 
Yes 78 1152 6.77 (5.42, 8.45) 
 
No 112 3191 3.51 (2.92, 4.22) 
Ever Father (males) 
   
  
 
Yes 6 221 2.71 (1.22, 6.04) 
  No  52 3972 1.31 (1.00, 1.72) 
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PY=person-year; IRR=incidence rate ratio; CI=confidence interval 
Caption: Table 5.2 presents number of events, person years, incidence rate ratios, 
and confidence intervals by time-fixed and time-updated variables.  
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Table 5.3 Hazard of HIV Acquisition by HIV Counseling and Testing Status 
  
Unadjusted MSM* 
     HR (95% CI) HR (95% CI) 
   HCT 
         
 
unexposed 1. 
  
1. 
       exposed  1.00 (0.78, 1.29) 0.59 (0.45, 0.78) 
   HCT=HIV Counseling and Testing, HR=Hazard Ratio, CI=Confidence Interval, MSM=marginal 
structural model. 
 
*Adjusted model controls for gender, age, distance to the clinic, year of study entry, educational 
attainment, sexual debut, number of sex partners in the last year, ever pregnant, ever fathered a 
child, and condom use at last sex. In the MSM, inverse probability of exposure and censoring 
weights are constructed using the same variables. 
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Figure 5.1 Study Population 
 
 
 
Caption: Figure 5.1 illustrates the number of youth 15-24 in the catchment area with  
at least two surveillance visits from 2006-2010. It shows the proportion included in 
and excluded from the analysis, and the proportion who received HCT at baseline and  
over time.  
 
 
·3985 HCT-exposed before baseline
·1054 HIV-infected before baseline
·6006 insufficient information (non-residents)
·3379 insufficient information (residents)
1167 HCT-exposed  (29%) 2792 HCT-unexposed (71%) 
1064 become  HCT-exposed (38%) 1728 remain  HCT-unexposed (62%)
18,383 youth with >2 surveillance visits from 2006-2010
3959 HIV-uninfected youth in the analysis 
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Figure 5.2 Adjusted Survival by HIV Counseling and Testing Status 
 
 
 
Caption: Figure 5.2 depicts the covariate-adjusted Kaplan Meier survival curves over a four year 
period comparing those who were HCT-unexposed to those who were HCT-exposed (HR=0.64).  
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CHAPTER VI: Aim 3 
The Awareness Framework: 
A Novel Approach for Understanding HIV Testing and Disclosure in HIV-discordant Dyads 
 
Introduction  
HIV testing and counseling (HCT) is rapidly being brought to scale in sub-Saharan 
Africa [1]. Scale-up has been driven primarily by the goal of linking HIV-infected persons to 
treatment. But what impact will HCT scale-up have on HIV prevention, especially as new 
biomedical HIV prevention interventions are introduced?  
Consistent with the Couples HIV Testing and Counseling Guidelines recently released by 
the World Health Organization, we assert that the prevention impact of HCT will likely hinge on 
whether both members of HIV-discordant dyads receive HCT and whether they share their HIV 
status with each other. However, we argue that a better understanding of the prevention impact of 
other HCT and disclosure strategies is needed. We introduce a novel framework for considering a 
person’s awareness of his/her own HIV status (through HCT) and his/her partner’s HIV status 
(through HIV disclosure) within HIV-discordant dyads. This framework is useful for 
understanding HCT trends, examining behavioral and biomedical risk in partnerships, and 
ultimately optimizing the impact of HIV prevention interventions.  
 
Describing the Awareness Framework 
HIV awareness within dyads involves two stages – testing and disclosure. In the first 
stage, persons can learn their own HIV status through HIV testing. In the second stage, they can 
inform their sex partners of their HIV status through disclosure. Within this framework, HIV 
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testing is a prerequisite for disclosure. In couples HCT, the two stages occur simultaneously in 
both partners. 
For prevention purposes, these two stages of awareness must be considered within HIV-
discordant dyads. HIV-discordant dyads account for all sexual transmission of HIV. We use the 
phrase “HIV-discordant dyad” broadly to refer to all sexual contacts with one HIV-infected and 
one HIV-uninfected person. These dyads can be homosexual or heterosexual, married or 
unmarried, long-standing or brief. We distinguish the term “HIV-discordant dyad,” from the more 
commonly used terms HIV-discordant “couple” or “partnership” which typically refers to a 
subset of dyads who are in long-term, stable, and often marital or cohabiting relationships.  
When HIV testing and disclosure in each member of the dyad are considered jointly, nine 
“awareness patterns” are possible (Table 6.1). In one extreme pattern, neither partner has been 
tested for HIV (pattern 1). In the other extreme pattern, both partners have been tested for HIV 
and have mutually disclosed their HIV status to each other (pattern 9). In an intermediate pattern, 
both partners have been tested individually but neither has disclosed to the other person (pattern 
5). Six additional patterns reflect other combinations of testing and disclosure—two in which 
only one partner has been tested but has not disclosed (patterns 2 and 4), two in which one only 
partner has been tested and has disclosed (patterns 3 and 7), and two in which both partners have 
been tested, but only one has disclosed (patterns 6 and 8). Several patterns, such as neither partner 
having ever been tested (pattern 1), have been described in the literature. Other patterns, such as 
pattern 6 or 8, where both partners have been tested, but only one has disclosed, have rarely been 
considered. 
Within an HIV-discordant dyad these patterns may change over time. For some dyads, 
mutual awareness (pattern 9) may occur soon after the relationship forms. For other dyads, it may 
take years to progress to mutual awareness. And for others still, especially those of brief duration, 
mutual awareness may never occur.  
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The Awareness Framework is likely to be an important mediator of HIV prevention, as 
depicted in Figure 6.1.  Different HCT strategies, such as individual versus couple HCT or client-
initiated versus provider-initiated HCT will likely result in different distributions of Awareness 
Framework patterns (i.e. pattern mixes). In turn, these pattern mixes are likely to affect the use of 
prevention strategies, including condoms, circumcision, pre-exposure prophylaxis (PrEP), and 
early antiretroviral therapy (ART) initiation, which reduce HIV transmission [2-3] or acquisition 
[3-8]. 
 
Relating HCT Strategies to the Awareness Framework 
A first set of questions to consider with the Awareness Framework is how HCT strategies 
impact the HIV-discordant dyad pattern mix. Both the type and scale of HCT strategies are 
important.  
The two main types of HCT strategies for individuals are voluntary counseling and 
testing (VCT) and provider initiated testing and counseling (PITC). For many years, the VCT 
paradigm accounted for most HCT in Africa. VCT is typically client-initiated and counseling-
intensive. Recently, there has been a paradigm shift towards PITC with more limited counseling, 
but broader reach through opt-out methods [9-10]. This paradigm shift is likely to result in fewer 
pattern 1 dyads (where neither partner has been tested) and more pattern 2, 4 and 5 dyads (where 
at least one partner has been tested). However, due to less intensive counseling, PITC often 
results in lower rates of HIV status disclosure than VCT [11]. Consequently, a smaller proportion 
of dyads would progress from patterns 2, 4 and 5 (where at least one partner has tested) to 
patterns 3, 6, 8, and 9 (where at least one partner has disclosed).  
Several HCT strategies are explicitly dyad-oriented, and these are likely to result in 
higher rates of disclosure. Couple’s HCT has been implemented in stand-alone VCT settings [12], 
antenatal clinics [13], and home-based HCT [14], leading to dyads being mutually aware of each 
other’s status (pattern 9). Intensive counselor-facilitated disclosure [15], provider-based partner 
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notification [16-17], and positive prevention counseling [18] have also yielded higher rates of 
disclosure by the HIV-infected partner (patterns 7, 8, and 9). Voucher-based recruitment, in 
which index patients are asked to give HCT vouchers to sex partners, also yields a higher share of 
dyads where at least one partner has disclosed (patterns 3, 6, 7, 8 and 9) [19]. Such strategies may 
be more costly and time-intensive in the short-term, but could prove worthwhile in the long-term 
if transmission events are averted. 
 
The Awareness Framework Pattern Mix 
A second, basic set of questions to address with the Awareness Framework is the 
prevalence of each pattern. Without this step it is not possible to determine which patterns are 
riskiest. Although all nine Awareness Framework patterns have never been characterized, 
individual self-report offers some insight into the pattern mix. In most African countries, before 
HIV treatment was available, very few persons had ever been tested, suggesting most dyads were 
in pattern 1 (neither partner tested) [20-23]. Currently, many individuals in SSA have been tested 
[1, 24] and in some settings a large proportion report disclosure to sex partners [25-29], 
suggesting a much broader distribution of patterns. However, even in a setting where 75% of 
persons have been tested and 75% of these persons have disclosed, only about a third of HIV-
discordant dyads would be expected to have mutually tested and disclosed (pattern 9).
2
  
Characterizing the pattern mix is possible in national or population-based surveys with 
questions on individual testing and disclosure, the ability to link dyads together, and HIV status. 
These characterizations would be an important first step to understanding the pattern mix at a 
point in time, and its evolution over time. 
 
 
                                                 
2
 If 75% of persons know their own HIV status and 75% of these persons disclose, then 56% of persons are 
likely to have tested and disclosed (0.75*0.75). The probability that both persons have tested and disclosed 
is 32% (0.56*0.56). This assumes testing and disclosure in the two partners are independent.  
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The Awareness Framework and HIV Prevention Strategies 
A third application of the Awareness Framework is to assess how each pattern affects use 
of different HIV prevention strategies, including condoms, pre-exposure prophylaxis, 
circumcision or early ART initiation.  
We hypothesize that pattern 9, where both partners have been tested and disclosed, is the 
most protective. In this pattern, both partners are aware that the HIV-uninfected partner is at risk 
for HIV acquisition. They can make decisions individually or together to protect the HIV-
uninfected partner. The relative transmission risk within the other eight patterns is less 
straightforward. In each, the presence of risk within the dyad is uncertain for at least one partner. 
For example, for a pattern 5 dyad, even though both persons have been tested, neither has 
disclosed and therefore neither is aware that the dyad is HIV-discordant. Similarly, in patterns 3 
or 7, when the status of one dyad member is known to both partners, they may assume incorrectly 
that the other dyad member has the same HIV status.  
 
Condom Use 
The combination of HCT and disclosure is known to have a strong impact on condom 
use. HIV-discordant dyads testing together (pattern 9), report dramatic increases in condom use, 
[31-32] and display lower HIV incidence rates [3, 33-34]. However, the association of each of the 
other eight patterns with consistent condom use is less clear because most studies have compared 
individuals’ behavior in one set of patterns to individuals’ behavior in a different set of patterns. 
For example, HIV-infected persons who know their own HIV status (patterns 4-9) tend to report 
much higher levels of condom use than HIV-infected persons who do not know their HIV status 
(patterns 1-3) [2, 16]. Such comparisons make it appear that all persons in patterns 4-9 have equal 
risk and that all persons in patterns 1-3 have equal risk, when in fact the risk within each set of 
patterns may vary considerably. Similarly, disclosure by HIV infected persons is often, though 
not always, associated with increases in condom use [25, 35-36], but this also has not been 
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studied by pattern. Separate comparisons of each pattern (1-8) to pattern 9 would provide a 
clearer picture of risk.  
 
New Biomedical HIV Prevention Strategies 
Access to new HIV prevention strategies will require HCT so persons can learn whether 
or not they are eligible. Only HIV-uninfected persons in patterns 2, 3, 5, 6, 8 or 9 (HIV-
uninfected partner tested) will be able to access pre-exposure prophylaxis, or male circumcision. 
Similarly, only HIV-infected persons in patterns 4-9 (HIV-infected partner tested) will be able to 
access early ART initiation. Clearly, HCT scale-up is essential for biomedical prevention.  
However, some of these patterns may be more strongly associated with adherence to 
biomedical prevention than others.  Just as pattern 9 has been associated with higher adherence to 
condoms, it is likely to be associated with higher adherence to PreP and early ART initiation [39-
40]. The groundbreaking HPTN 052 trial of early ART initiation by HIV-infected persons is an 
important example of this possibility [41]. This trial was conducted among mutually aware HIV-
discordant dyads, all in pattern 9. In this trial not only did 95% of couples report consistent 
condom use, but adherence to ART was very high. When early ART initiation is implemented 
elsewhere, some persons will be in pattern 9 dyads, but others will undoubtedly be in pattern 4-8 
dyads. HIV-infected persons in these other patterns may be less likely to use condoms and may 
face partner-level barriers to adherence. As a result, effectiveness might be undermined.  
The Awareness Framework may also help explain different efficacy results in the PrEP 
trials. In both FEM-PrEP and Partners PrEP, participants were taking oral doses of FTC/TDF 
daily. But in the FEM-PrEP trial, HIV-uninfected women enrolled as individuals and could have 
been in any of several dyad patterns (2, 3, 5, 6, 8, or 9) or in HIV-concordant-negative dyads. In 
contrast, in the Partners PrEP study all participants were in mutually aware HIV-discordant dyads 
(pattern 9). In FEM-PrEP adherence was poor and PrEP was not efficacious [42]. In contrast, in 
Partners PrEP, adherence to PreP was excellent  [43], and acquisition was reduced by 75% [8]. 
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The different pattern mixes may have played a role in differences in adherence and ultimately 
efficacy.  
 
Discussion 
The Awareness Framework offers two novel contributions to our thinking about HIV 
prevention. First, it adds nuance to the discussion about HIV status awareness within HIV-
discordant dyads. Although, many have advocated for couple-based strategies for Africa [44-48], 
none have delineated all of the possible alternatives to mutual awareness, even though they may 
be quite meaningful. Second, it helps us think about how different HCT strategies may translate 
into different utilization of many HIV prevention strategies and ultimately different effectiveness.  
The Awareness Framework has real-world relevance for HTC programs. The types of 
HTC that are implemented will affect the Awareness Framework patterns which could have a 
profound impact on use of proven HIV prevention interventions. Assessing the shift in the 
Awareness Framework patterns over time will identify the gaps in testing or disclosure and in 
HIV-infected or HIV-uninfected persons. A better understanding of these gaps is necessary for 
determining how best to direct resources.  
The Awareness Framework is a simple representation of the patterns of testing and 
disclosure within dyads. It is not a tool for understanding why people seek HCT or disclose their 
HIV status to their sexual partners, nor is it a conceptual model for understanding why some 
patterns are more protective than others. It also does not address whether all means of achieving a 
certain pattern are equally effective. Certainly the nine patterns are not the only factors 
underlying sexual risk-taking in partnerships. Gender, dyad stability, substance use, intimate 
partner violence, age gaps, and sexual communication are other key factors that are undoubtedly 
critical within dyads and should not be overlooked [35, 49-51].  
Additionally, although HIV-discordant dyads are the primary unit of analysis within the 
framework, understanding how these dyads relate to sexual networks is important. HIV-
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discordant dyads in riskier patterns will have a larger impact on HIV incidence if they have a 
central position in a sexual network or are engaging in higher levels of concurrency.  
Additionally, although HIV-discordant dyads are the primary unit of analysis within the 
framework, understanding how these dyads relate to the sexual networks they are a part of is 
essential. HIV-discordant dyads in riskier patterns will have a larger impact on HIV incidence if 
they are engaging in higher levels of concurrency or have a more central position in a sexual 
network.  
Overall the Awareness Framework provides a deeper, more nuanced consideration of 
HIV awareness and disclosure, which underlies all HIV prevention. Ignoring the complexity of 
testing and disclosure relationships within dyads may lead to oversimplified understandings of 
HIV prevention, suboptimal HCT strategies, and missed HIV prevention opportunities.   
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Tables and Figures 
 
Table 6.1: The Awareness Framework—Nine Patterns for HIV-Discordant Dyads 
 
 
HIV-uninfected partner  
HIV-infected partner 
Has not tested for HIV,  
has not disclosed 
Has tested for HIV, 
has not disclosed 
Has tested for HIV, 
has disclosed 
 
Has not tested for HIV,  
has not disclosed 
1 
HIV-infected not tested, 
HIV-uninfected not tested 
4 
HIV-infected tested,  
HIV-uninfected not tested 
7 
HIV-infected disclosed,  
HIV-uninfected not tested 
 
Has tested for HIV, 
has not disclosed 
2 
HIV-infected not tested,  
HIV-uninfected tested 
5 
HIV-infected tested, 
HIV-uninfected tested 
8  
HIV-infected disclosed,  
HIV-uninfected tested 
 
Has tested for HIV, 
has disclosed 
3  
HIV-infected not tested,  
HIV-uninfected disclosed 
6 
HIV-infected tested,  
HIV-uninfected disclosed 
  9  
HIV-infected disclosed, 
HIV-uninfected disclosed 
 
Caption: There are nine possible awareness patterns within HIV-discordant dyads. The HIV-
infected person may or may not have been tested, and if tested, may or may not have disclosed. 
Similarly, the HIV-uninfected person may or may not have been tested, and if tested, may or may 
not have disclosed. Understanding how each of the nine patterns is associated with uptake of and 
adherence to different HIV prevention strategies is important.  
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Figure 6.1: Role of the Awareness Framework in HIV Prevention 
 
 
 
 
 
 
 
 
 
Caption: The Awareness Framework is likely to be an important mediator of HIV prevention. 
Different HCT strategies will lead to different Awareness Framework pattern mixes. In turn, 
these pattern mixes are likely to impact the utilization of different HIV prevention strategies, 
including condoms, circumcision, pre-exposure prophylaxis, and early ART initiation. These 
strategies have been shown to lower the probability of HIV transmission or acquisition. 
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CHAPTER VII: Discussion 
HIV Counseling and Testing (HCT) has been scaled up rapidly in many parts sub-
Saharan Africa, over the last decade [1]. HCT is indisputably an essential first step for linking 
HIV-infected persons to care and treatment, but the impact of HCT on HIV prevention, especially 
among HIV-uninfected persons, has remained uncertain. This dissertation addressed the 
overarching question of what impact HCT has on HIV prevention. This overarching question can 
be broken down into several smaller questions. What impact does HCT have on behavioral and 
biomedical prevention strategies? What impact does HCT have on HIV acquisition versus HIV 
transmission? Does the impact vary in populations of individuals versus couples, men versus 
women, adults versus youth? Understanding the answers to some of these questions can inform 
the larger, more relevant public health question: how can the prevention impact of HCT be 
optimized? This dissertation addressed a subset of these questions in three aims: whether couples 
HCT had an impact on consistent condom use among HIV-discordant couples (Aim 1), whether 
HCT had an impact on HIV acquisition among HIV-uninfected youth (Aim 2) and whether nine 
different patterns of HCT and disclosure may impact prevention in HIV-discordant dyads (Aim 
3).   
 
Contributions  
In this dissertation, two different types of HCT were shown to be protective in two 
distinct settings using two different outcome measures. In the first aim, couples’ HCT was 
associated with high uptake of consistent condom use among HIV-discordant couples enrolled in 
an HIV prevention trial. Uptake occurred immediately and was sustained for one year of follow-
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up. In the second aim, HCT was protective against HIV acquisition among HIV-uninfected youth 
over four years of follow-up.  
In addition, we developed a new conceptual model, called the Awareness Framework, to 
help explain disparate findings in the HIV counseling and testing and disclosure literatures and 
facililate a more nuanced discussion of these topics.   
 
Contributions of Aim 1 
Aim 1 addressed whether HCT led to condom uptake and consistent condom use among 
HIV-discordant couples. I hypothesized that at baseline those recently tested would report more 
unprotected sex acts than those previously tested due to lack of awareness for part of the previous 
month. I also hypothesized that once both groups had been aware of their own HIV status and 
their partner’s HIV status for the entire preceding month that sexual behavior would be 
comparable. My findings in this aim supported these hypotheses. 
Three main comparisons were made in this aim. The first comparison was cross-
sectional. At baseline, HIV-infected persons who had learned that they were HIV-infected <7 
days previously were compared to persons who had known they were HIV-infected for >30 days. 
Those who had just learned that they were HIV-infected were much more likely to report 
engaging in unprotected sex (OR: 9.0) and having more unprotected sexual acts (relative number: 
1.7) than persons who had been aware for >30 days. The second and third comparisons were 
longitudinal. In the second comparison, HIV-infected persons who had learned that they were 
HIV-infected <7 days before baseline were compared to themselves at later time points, when 
they had been aware that they were in HIV-discordant relationships for at least one month. These 
HIV-infected persons were considerably less likely to report any unprotected sex once they were 
aware that they were in an HIV-discordant relationship (OR: 0.03), a trend that persisted for one 
year (OR: 0.04). In the third comparison HIV-infected persons who had been aware of their own 
HIV status for >30 days before baseline, but not necessarily their partner’s HIV status, were 
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compared to themselves one month later when they had known their own and their partners’ HIV 
status for at least one month. Persons were somewhat less likely to report engaging in unprotected 
sex once they had been aware of both their own HIV status and their partners’ HIV status for one 
month (OR: 0.45) and this also persisted for one year (OR: 0.66).  
The strength of this analysis was that it included a comparison of two different groups at 
one point in time and comparisons of each group over time. If only the baseline comparison had 
been conducted, it would be possible to argue that a certain type of person (e.g. care-seekers), 
rather than HCT, explained baseline differences in condom use. Individual level factors could 
have confounded the relationship. If only the longitudinal comparisons had been conducted it 
would be possible to argue that other time-varying factors (e.g. participation in the study), and not 
HCT explained the uptake of consistent condom use. Temporal factors could have confounded 
the relationship. However, having both comparisons together makes it unlikely that only 
individual or only temporal factors were responsible for behavior change. If only individual level 
factors had been responsible, it would be difficult to explain the uptake of consistent condom use 
in both groups over time. If only temporal factors were responsible, it would be difficult to 
explain the cross-sectional differences at baseline. 
It is worth noting that not only was mutual awareness of HIV status associated with 
consistent condom use, but it was strongly associated with consistent condom use. This 
relationship was not modified by gender or age. Additionally, after extensive exploration of the 
associations between demographic and dyad-level characteristics with consistent condom use, 
HCT was not simply one factor associated with consistent condom use, but rather appeared the 
strongest factor associated with consistent condom use.  
 Our results are consistent with previous findings suggesting that couples HCT leads to 
substantial increases in consistent condom use [2-5]. However, we addressed this question in a 
new context. This is the first study, to our knowledge, to rigorously assess the impact of couples’ 
HCT on sexual behavior in South Africa, a country with a unique cultural and historical context, 
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including a long period of HIV denialism [6]. It was also the first study, to our knowledge, to 
address this set of questions in an era when HIV treatment was becoming more widely available. 
Different contexts could give rise to different findings. Replication of previous findings in new 
settings is a critical part of the scientific process. These findings add robustness to this body of 
knowledge.  
 Due to the measurement points of previous studies, most did not address the question of 
how quickly uptake of consistent condom use occurred following couples HCT. Understanding 
whether this is a behavior that couples adopt right away or one that takes time is important. 
Because Partners in Prevention HSV/HIV Transmission Study assessed sexual behavior one 
month after baseline, this question could be assessed in this analysis. Our analysis is one of the 
first to show that condom uptake occurred within the first week after couples HCT [9], suggesting 
one counseling session was sufficient for adoption of this behavior. This finding has important 
public health relevance for all HIV-infected persons, but particular importance within the context 
of acute HIV infection. During acute HIV infection persons are highly infectious for only a brief 
period. During this period, immediate adoption of consistent condom use could have large 
impacts on the onward spread of HIV [7]. Our findings merit replication in persons identified 
with acute HIV infection.  
 
Contribution of Aim 2 
 Aim 2 addressed whether individual HCT led to lower rates of HIV acquisition among 
HIV-uninfected youth in a high prevalence part of South Africa. I had hypothesized that HIV 
acquisition rates would be higher in those who were aware of their HIV status from HCT. Results 
from this aim refuted this hypothesis. In unadjusted analysis, the hazard of HIV acquisition 
among those exposed- and unexposed- to HCT were not statistically different (approximately 3 
cases per 100 person years). But after appropriate weighting for time-varying risk factors and 
censoring, HIV-uninfected youth who had received couples’ HCT experienced a 30% lower 
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hazard of HIV acquisition than their HIV-uninfected counterparts. This effect did not attenuate 
over time. 
 The difference between the null unadjusted findings and the protective weighted findings 
is due to differences between testers and non-testers. Testers were at greater risk for HIV 
acquisition than non-testers. First, testers were more likely to be female, a group that is more 
biologically susceptible to HIV at young ages. They were more likely to have experienced sexual 
debut. And they were more likely to have ever been pregnant and sexually active in the last year. 
When I controlled for these factors in standard models or weighted for these factors in marginal 
structural models, it became apparent that HCT was in fact protective. HCT had made the high 
risk youth more like the low risk youth.  
 This is one of a few studies to address the impact of HCT on HIV acquisition 
longitudinally with an HIV endpoint [8-10]. There have been several studies to look at the 
associations between HCT and HIV status in cross-sectional data, but these studies cannot 
determine the temporal ordering of HCT and HIV acquisition. Similarly, there have been several 
longitudinal studies among HIV-uninfected persons assessing the impact of HCT on sexual 
behavior endpoints [11-12] or other biomarkers, such as gonorrhea or pregnancy [13]. However, 
to rigorously assess the question of HCT on HIV acquisition, HIV endpoints are needed. In this 
analysis, independence of the exposure and the outcome coupled with the large number of HIV 
endpoints allowed for this assessment.  
This analysis focused on youth, a group at high risk for HIV acquisition and one in which 
the impact of HCT on HIV acquisition has not been assessed. Additionally, the ACDIS dataset 
was better able to address this question in youth. Most adults 25 years old and older had 1) 
already acquired HIV, 2) reported knowing their HIV status at the time of the first HIV report, 3) 
had migrated, or 3) refused to provide blood for the sero-survey. As a result, very few adults were 
eligible for inclusion in the analysis. For both scientific and practical reasons, this analysis was 
therefore restricted to youth.  
 124 
 
Our findings differ from previous work conducted primarily among adults, suggesting 
HCT offered to individuals has no effect, or even a small harmful effect, on HIV acquisition [8-
10]. The difference between our findings and previous findings may be due to differences in the 
analytic methods used or the populations under consideration.  
Our analysis employed rigorous statistical methods. Other analyses used only baseline 
HCT status and baseline covariates, rather than time-varying HCT status and time-varying 
covariates. Our analysis was able to capture the time-varying nature of HCT, and appropriately 
account for time-varying factors. We did this using standard analytic methods and marginal 
structural models.  
 This was the first analysis to address this question exclusively among young persons. It is 
possible that young persons are able to change their behavior more easily than adults. In this area, 
due to the high price of lobola (bride price), marriage does not typically occur before the age of 
25, and cohabitation before marriage is rare. Thus young persons in this cohort tend to be in less 
stable relationships, ones where condom negotiation may be easier. In exploratory analyses those 
who were HCT-exposed reported greater condom use at last sex than those who were HCT-
unexposed in the period after HCT report, suggesting this may be the mechanism of action. 
Another possibility is that HIV-uninfected youth were more likely to find other HIV-uninfected 
sex partners. It is also possible that there is a cohort effect and that these young persons, growing 
up in a period when HIV is recognized and care is available, are more motivated to reduce their 
risk following HCT than persons in previous years. Whatever the reason, this is an especially 
timely issue as South Africa debates the introduction of HCT into secondary schools [14]. 
Replication of these results in experimental, quasi-experimental, or even other observational 
settings is important.  
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Contribution of Aim 3 
 Finally, in Aim 3 we developed a Framework to clarify thinking about the relationships 
between two types of HIV awareness in HIV-discordant dyads (testing and disclosure) and 
describe how these relationships may be associated with HIV prevention. The Framework can be 
used to enhance understanding of a variety of HIV prevention research, including Aims 1 and 2 
of this dissertation.  
 Aim 1 contained three primary comparisons, as described above. These comparisons can 
also be described in terms of the Awareness Framework. Baseline results compared dyads in 
which the HIV-infected person had not tested (over until very recently) (patterns 1-3) with dyads 
in which the HIV-infected person had tested (patterns 4-9). Among HIV-infected persons, testing 
was more protective. The first longitudinal results compared dyads in which the HIV-infected 
person had not tested (patterns 1-3) with dyads in which both partners were mutually aware 
(patterns 9). Mutual awareness was much more protective than non-awareness. The second 
longitudinal results were a comparison of dyads in which at least the HIV-infected partner was 
aware of his/her own status (patterns 4-9) with dyads that are mutually aware (pattern 9). Mutual 
awareness was somewhat more protective than individual awareness by the HIV-infected partner.  
It is more difficult to apply the Framework to Aim 2 because it is not possible to 
determine which youth were in HIV-discordant dyads. However, many youth, including all those 
who sero-converted, were in HIV-discordant dyads, unless they acquired HIV through a non-
sexual route. Of these HIV-discordant dyads, among the HCT-unexposed youth, the HIV-
uninfected partner had not tested (patterns 1, 4, or 7) and in the HCT-exposed youth, the HIV-
uninfected partner had tested (patterns 2, 3, 5, 6, 8, or 9). Patterns in which the HIV-uninfected 
youth had tested were more protective than the patterns in which the HIV-uninfected youth had 
not tested. 
In Table 7.1 I summarize the results from Aims 1 and 2 using the awareness framework 
patterns. When looking at these comparisons, there are a few points that are worth noting. First, 
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mutual awareness (pattern 9) is always in the more protective group. Second, non-awareness by 
both persons (pattern 1) is always in the less protective group. And third, all of the other patterns 
are sometimes in the more protective group and sometimes in the less protective group.  
Although these sets of comparisons are informative, they are unsatisfying, because we are 
unable to isolate single patterns and instead are looking at associations between pattern mixes. 
For example, the baseline cross sectional comparison in Aim 1, compares HIV-infected persons 
who are aware (patterns 4-9) with HIV-infected persons who are unaware (patterns 1-3). Are all 
three HCT-unexposed patterns (patterns 1-3) equally risky? Are all six HCT-exposed patterns 
(patterns 4-9) equally protective? Or are certain patterns more prevalent and driving the 
associations? These questions cannot be answered with the available data, but are important areas 
for future research.  
 
Summary of Contributions  
Overall, Aim 1 adds to the robustness of the finding that learning that one is in an HIV-
discordant couples is strongly associated with consistent condom use, and this is adopted soon 
after HCT. Aim 2 suggests that among youth HCT leads to a moderate reduction in HIV 
incidence. And Aim 3 helps explain some of the discrepancies in the literature and suggests a 
direction for future research.  
 
Limitations   
 In spite of the contributions made in this dissertation, both analytic aims have important 
limitations. Both aims relied on secondary data analyses, and as such were constrained by 
information that was already available. These constraints raise concerns about both bias and 
generalizability. Aim 3 also has limitations related to what it can and cannot explain. 
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Aim 1 Limitations 
The first potential source of bias in Aim 1 is information bias. Both the exposure and the 
outcome rely on behavioral self-report. Participants reported the timing of their first HIV test. 
They also reported on their own sexual behavior in the last month. Subjects may have had 
difficulty recalling this information and may have provided socially desirable responses. 
Importantly, these two sources of bias may have been non-independent [15]. There could be 
factors, such as poor memory or social desirability, that affected the reporting of both the 
exposure and the outcome. This bias could be differential. At baseline persons who were HCT-
exposed may have been more likely to under-report unprotected sex than persons who were HCT-
unexposed, as persons who knew they were HIV-infected may have experienced more social 
desirability. If this had occurred, baseline results would have been exaggerated. However, due to 
the large effect size seen at baseline, this phenomenon would have to be very strong to entirely 
nullify the findings.  
It is also possible that there is residual confounding in Aim 1. Although a broad range of 
individual and dyad-level factors were explored as potential confounders, there may have been 
unmeasured factors that we could not control for. A personality trait, such as a person’s 
predisposition to risk, is one possible unmeasured confounder. Risk-averse persons may have 
been more likely to seek HCT earlier and may have been more likely to use condoms, inducing a 
spurious association. However, if this were the case, the group who had been HCT-exposed 
earlier would be expected to not only report less unprotected sex at baseline, but also less 
unprotected sex over time. This was not the case. Persons who were HCT-exposed at baseline 
reported slightly more unprotected sex over time.  
 There is also a concern about who these results can be generalized to. Do stable couples 
who participate in the study differ substantially from stable couples eligible for the study who did 
not participate? Couples who participate in a prevention trial are more likely to be concerned 
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about prevention. By enrolling together they may also have more amicable relationships and be 
better able to negotiate prevention behaviors. If couples HCT were offered to all couples, would 
the same high rates of HCT be observed? This is something that cannot be judged from the data 
available from the trial. 
 A related concern is whether a study of stable HIV-discordant couples is important for 
the transmission dynamics of a generalized epidemic. Although risk may be high within HIV-
discordant couples, some have argued that they are isolated from larger sexual networks. Some 
investigators have suggested that stable HIV-discordant couples in SSA may account for as little 
as 14% of transmission [16]. It is worth noting, however, that many couples in this trial were not 
disconnected from larger sexual networks. In spite of few couples reporting outside partners at 
baseline, the number of outside partners increased over time, and one third of transmissions seen 
in the overall study were not genetically linked to the HIV-infected partner, suggesting they came 
from an outside relationships [17]. These findings suggest that these dyads are, in fact, 
interconnected to other sexual networks, at least through the HIV-uninfected partners. Counseling 
for these HIV-discordant dyads must not only focus on the dyad, but also on how to negotiate 
sexual behavior outside the relationship.  
 
Aim 2 Limitations 
 Although ACDIS theoretically has information on each variable for each person in each 
year, in reality there is considerable missing information. Many included participants had 
sufficient information for inclusion in the analysis, but missing exposure information, outcome 
information, or covariate information during follow-up. Additionally, many persons had 
insufficient information for inclusion in the analysis at all. I employed a number of analytic 
techniques to address these concerns—multiple imputation of missing covariates, inverse 
probability weighting of persons who refused participation at later time points, sensitivity 
analysis of longer gap-lengths between exposures, and exploration of persons who refused. In all 
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cases, results were robust to these assumptions and sensitivity analyeses. However, given the 
substantial amount of missing information, it is still possible that the relationship between HCT 
and HIV acquisition was different in the missing data than it was in the non-missing data.  
 
Aim 3 Limitations 
The main limitation of the Awareness Framework is that it does not capture the 
complexity of different contexts and sexual behavior. Certainly the nine patterns are not the only 
factors underlying sexual risk-taking in partnerships. Gender, dyad stability, substance use, 
intimate partner violence, age gaps, and sexual communication are other key factors that are 
undoubtedly critical within HIV-discordant dyads and should not be overlooked [18-21]. 
However, although the awareness framework does not address these factors explicitly, the 
relationship between the Awareness Framework and these other factors of interest can be 
accommodated easily. For example, riskiness of the nine patterns can be assessed separately 
among men and women.  
The framework may be also be adding unnecessary complexity. Once the framework is 
properly studied, it may turn out that certain patterns do not exist or do not differ from one 
another. For example, it may be incredibly rare for an HIV-infected person to have tested and 
disclosed, but for an HIV-uninfected person to have tested, but not disclosed (pattern 8). Further 
exploration could also reveal that certain patterns are equally risky, such as when an HIV-
uninfected person has tested, but not disclosed (pattern 2) and when an HIV-uninfected person 
has tested and disclosed (pattern 3). However, without future research this cannot be determined.  
 
Future Research 
Research Stemming from Aim 1 
One critical question that Aim 1 could not address was whether it was mutual awareness 
of each other’s HIV status, the nature of couples counseling, or both together that was protective. 
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Answering this question would require comparisons of different types of mutually aware dyads 
(both in pattern 9). Assessing this question would require a comparison of couples who had 
undergone couples HCT together with couples who had undergone HCT separately and then 
disclosed to one another. Such a comparison would provide insight into whether it was the 
couples counseling or simply the mutual awareness that was the more protective factor.   
 
Research Stemming from Aim 2 
Findings from Aim 2 suggest several directions for future research. First, given the 
potential for bias in this analysis or differences between populations, replication of these results 
in similar datasets is important. There are other sites throughout sub-Saharan Africa that collect 
similar demographic and HIV surveillance data and replication at these sites is warranted [22]. 
Second, although we conducted exploratory analyses of the underlying causal mechanisms, a 
more detailed assessment of the causal mechanisms is important. There could be factors that were 
not assessed, such as sero-sorting, that were important.  And third, although there has been rapid 
expansion of HCT in the catchment area since 2004, there are still many youth (both HIV-
infected and HIV-uninfected) who do not know their HIV status [23]. Research is needed to 
compare the effectiveness and cost-effectiveness of different strategies, such as clinic-, home-, 
and school-based testing for HCT uptake among youth.  
 
Research Stemming from Aim 3 
The Awareness Framework suggests three key directions for future research. First, work 
is needed to simply asses the pattern mix in different populations. Second, a better understanding 
of which HCT strategies lead to each pattern mix is needed. And third, there is a need for a better 
assessment of how each pattern is associated with uptake of and adherence to different behavioral 
and biomedical HIV prevention strategies, such as circumcision [24-26], pre-exposure 
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prophylaxis, [27-29], and early treatment initiation [30]. Findings from this research will inform 
discussions about how best to use HCT to maximize a range of HIV prevention interventions.  
  
 
Conclusions 
HCT has been introduced rapidly and intensively into the South Africa context. 
Nonethless, current HCT strategies rarely involve partners and frequently do not reach youth. The 
next phase of HCT policy must address HIV prevention more aggressively, both in terms of the 
populations targeted and the types of services that are delivered. For HIV infected persons this 
will of course mean addressing the landmark findings that early ART intiatition is effective at 
reducing transmission. But it must also involve using HCT to identify HIV-discordant dyads and 
ensure that they are mutually aware, and reaching youth with HCT before they become infected. 
South Africa’s HCT campaign was a successful step towards better coverage, but it cannot be the 
final step. The prevention challenges that South Africa faces are too great. 
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Tables and Figures 
 
Table 7.1: Comparisons of Aims 1 and 2 using the Awareness Framework Patterns  
 Reference Group Comparison Group Outcome 
Aim 1 
Cross-sectional  1, 2, 3  4, 5, 6, 7, 8, 9 4-9 are more 
protective.  
Longitudinal 1 1, 2, 3 9 9 is more protective 
Longitudinal 2 4, 5, 6, 7, 8 9 9 is more protective  
Aim 2 
Longitudinal 2 1, 4, 7 2, 3, 5, 6, 8, 9 2, 3, 5, 6, 8, and 9 
are more protective  
 
Caption: Table 7.1 summarizes the comparisons made in this dissertation using the awareness 
framework. In this dissertation, pattern 9 is always in the more protective group and pattern 1 is 
always in the less protective group. The other patterns are sometimes more protective and 
sometimes less protective.  
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